<SEC-DOCUMENT>0001437749-23-034827.txt : 20231219
<SEC-HEADER>0001437749-23-034827.hdr.sgml : 20231219
<ACCEPTANCE-DATETIME>20231219083013
ACCESSION NUMBER:		0001437749-23-034827
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20231214
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231219
DATE AS OF CHANGE:		20231219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		231495677

	BUSINESS ADDRESS:	
		STREET 1:		101 CRAWFORDS CORNER RD
		STREET 2:		SUITE 4116
		CITY:			HOLMDEL
		STATE:			NJ
		ZIP:			07733
		BUSINESS PHONE:		7323591100

	MAIL ADDRESS:	
		STREET 1:		101 CRAWFORDS CORNER RD
		STREET 2:		SUITE 4116
		CITY:			HOLMDEL
		STATE:			NJ
		ZIP:			07733

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20231218_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:bkyi="http://www.bkyi.com/20231214"><head>
	<title>bkyi20231218_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 12/18/2023 11:47:50 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0001019034</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="bkyi-20231214.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001019034</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-12-14</xbrli:startDate>
<xbrli:endDate>2023-12-14</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Washington, D.C. 20549</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Pursuant to Section&#xa0;13 or 15(d) of the Securities Exchange Act of 1934</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 14, 2023</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>BIO-key International, Inc.</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;display:none;"><ix:nonNumeric contextRef="d20238K" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:15.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction of incorporation)</div>
			</td>
			<td style="vertical-align:top;width:15.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>1-13463</b></ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:top;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>41-1741861</b></ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>101 Crawfords Corner Road</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine2"><b>Suite 4116</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>Holmdel</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressStateOrProvince"><b>NJ</b></ix:nonNumeric></b>&#xa0;<ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>07733</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices) (Zip Code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode"><b>732</b></ix:nonNumeric>)</b>&#xa0;<ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber"><b>359-1100</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric> &#xa0;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric> &#xa0;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric> &#xa0;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric> &#xa0;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: middle; width: 15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.3%; border-top: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol(s)</div>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: middle; width: 15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:TradingSymbol">BKYI</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric>&#xa0;Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:15.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:15.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Item 3.03</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Material Modification to Rights of Security Holders. </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">To the extent required by Item 3.03 of Form 8-K, the information set forth under Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Item 5.02</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>BIO-key International, Inc. 2023 Stock Incentive Plan </i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 14, 2023, the stockholders of BIO-key International, Inc. (the &#8220;Company&#8221;), upon recommendation of the Board of Directors of the Company (the &#8220;Board&#8221;), approved the BIO-Key International, Inc. 2023 Stock Incentive Plan (the &#8220;2023 Plan&#8221;) at a special meeting of stockholders (the &#8220;Special Meeting&#8221;). The Board, upon recommendation of the Compensation Committee, previously approved the 2023 Plan subject to approval by the Company&#8217;s stockholders.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The 2023 Plan became effective immediately upon approval by the Company&#8217;s stockholders and will expire on December 13, 2033, unless terminated earlier. The 2023 Plan permits the Board, or a committee thereof, to grant to eligible employees, non-employee directors, consultants, advisors and independent contractors of the Company non-statutory and incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units, deferred stock units, performance awards, and other stock-based awards. The Board, or a committee thereof, may select 2023 Plan participants and determine the nature and amount of awards to be granted. Subject to adjustment as provided in the 2023 Plan, the maximum number of shares of the Company&#8217;s common stock, par value $0.0001 (&#8220;Common Stock&#8221;), available for issuance under the 2023 Plan is 6,000,000.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the text of the 2023 Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. A more detailed summary of the 2023 Plan can be found in the definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on November 24, 2023 (the &#8220;Proxy Statement&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Item 5.03</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">At the above referenced Special Meeting, stockholders of the Company approved an amendment to the Company&#8217;s Certificate of Incorporation, as amended, to effect a reverse stock split of the Common Stock in the range of 1-for-6 to 1-for-20, with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse stock split to be determined by the Board, in its discretion, no later than December 22, 2023 (the &#8220;Proposal&#8221;). A more detailed summary of the Proposal can be found in the Proxy Statement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">After the Special Meeting, on December 14, 2023, the Board set the reverse stock split ratio at 1-for-18, and on December 19, 2023, the Company filed a Certificate of Amendment (the &#8220;Certificate of Amendment&#8221;) with the Secretary of State of the State of Delaware to effect the reverse stock split. The Certificate of Amendment will become effective at 5:00 p.m., Eastern Time, on December 20, 2023. The Common Stock will begin trading on the Nasdaq Capital Market on a split-adjusted basis on December 21, 2023 under a new CUSIP number, 09060C507.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">At the effective time of the 1-for-18 reverse stock split, every 18 issued and outstanding shares of Common Stock will be converted into one (1) issued and outstanding share of Common Stock, and the total outstanding shares of Common Stock will be reduced from approximately 16,900,000 to approximately 941,000. The number of authorized shares and the par value per share will remain unchanged. No fractional shares will be issued in connection with the reverse stock split.&#xa0;Any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The foregoing description of the Certificate of Amendment is not complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Cautionary Note Regarding Forward-Looking Statements</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">All statements other than statements of historical facts contained in this Current Report on Form 8-K, including statements regarding the timing and effect of the reverse stock split, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;should,&#8221; &#8220;estimate,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;future,&#8221; &#8220;plan,&#8221; &#8220;intend&#8221; and &#8220;expect&#8221; and similar expressions generally identify forward-looking statements. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, risks associated with the reverse stock split, the Company&#8217;s ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of the Common Stock, and numerous other matters of national, regional and global scale, including those set forth under the caption &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, presently or in the future. Except as required by law, the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Item 5.07</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Submission of Matters to a Vote of Security Holders.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 14, 2023, the Company held the above referenced Special Meeting. As of the close of business on October 31, 2023, the record date for the Special Meeting, there were 13,668,894 shares of Common Stock outstanding and entitled to vote at the Special Meeting. Each shares of Common Stock was entitled to one vote. Stockholders holding an aggregate of 7,455,086 shares of Common Stock entitled to vote at the Special Meeting, representing 54.4% of the outstanding shares of Common Stock as of the record date, and which constituted a quorum thereof, were present in person or represented by proxy at the Special Meeting.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">At the Special Meeting, the Company&#8217;s stockholders considered two proposals, each of which is described in more detail in the Proxy Statement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The final results of the stockholder vote on each proposal brought before the Special Meeting are set forth below:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Proposal 1. The Company&#8217;s stockholders approved the proposed amendment to the Company&#8217;s Certificate of Incorporation, as amended, to effect a reverse split of the Company&#8217;s issued and outstanding Common Stock at a ratio between 1-for-6 and 1-for-20, with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse split to be determined by the Board, in its discretion, following stockholder approval (if obtained), but no later than December 22, 2023.&#xa0; The final voting results were as follows:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Votes For</span></b></div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Votes Against</span></b></div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Abstentions</span></b></div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Broker Non-Votes</span></b></div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">6,139,952</div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1,283,994</div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">31,140</div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">-</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Proposal 2. The Company&#8217;s stockholders approved the BIO-key International, Inc. 2023 Stock Incentive Plan.&#xa0; The final voting results were as follows:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Votes For</span></b></div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Votes Against</span></b></div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Abstentions</span></b></div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">Broker Non-Votes</span></b></div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3,869,452</div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">856,044</div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">26,708</div>
			</td>
			<td style="vertical-align:top;width:11.4%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2,702,882</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Item 8.01</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Other Events.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 19, 2023, the Company issued a press release announcing the effectiveness of the reverse stock split, which is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Item 9.01</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.1</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ex_607847.htm" style="-sec-extract:exhibit;">Certificate of Amendment (filed herewith)</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10.1</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_607848.htm" style="-sec-extract:exhibit;">BIO-key International, Inc. 2023 Stock Incentive Plan (filed herewith)</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">99.1</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_608212.htm" style="-sec-extract:exhibit;">Press Release dated December 19, 2023 (furnished herewith)</a></div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">104</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded with the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; margin: 0pt;">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:17.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">BIO-KEY INTERNATIONAL, INC.&#xa0;</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: December 19, 2023&#xa0;</div>
			</td>
			<td style="vertical-align:top;width:1.4%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:16%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/&#xa0;Cecilia C. Welch</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cecilia C. Welch&#xa0;</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial&#xa0;Officer&#xa0;</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex_607847.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html><head>
	<title>ex_607847.htm</title>

	<!-- Generated by ThunderDome Portal - 12/18/2023 5:37:18 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 3.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATE OF AMENDMENT</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TO THE</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATE OF INCORPORATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>BIO-KEY INTERNATIONAL, INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 242 of the</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>General Corporation Law of the State of Delaware</b>&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">BIO-key International, Inc., a Delaware corporation (the &#8220;<b><i>Corporation</i></b>&#8221;), does hereby certify as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FIRST: Upon the effectiveness (the &#8220;<b><i>Effective Time</i></b>&#8221;) pursuant to the General Corporation Law of the State of Delaware (the &#8220;<b><i>DGCL</i></b>&#8221;) of this Certificate of Amendment to the Certificate of Incorporation of the Corporation, each 18 shares of the Corporation&#8217;s common stock, par value $0.0001 per share (the &#8220;<b><i>Common Stock</i></b>&#8221;), issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time shall automatically be combined into one (1)&nbsp;validly issued, fully paid and non-assessable share of Common Stock without any further action by the Corporation or the holder thereof, subject to the treatment of fractional interests as described below. Notwithstanding the immediately preceding sentence, no fractional shares will be issued in connection with the reverse stock split. Stockholders of record who otherwise would be entitled to receive fractional shares, will be entitled to rounding up of their fractional share to the nearest whole share. No stockholder will receive cash in lieu of fractional shares. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (the &#8220;<b><i>Old Certificates</i></b>&#8221;) shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the adjustment for fractional shares as described above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">SECOND: The foregoing amendment was duly adopted in accordance with Section 242 of the DGCL.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">THIRD: This Certificate of Amendment shall become effective at 5:00 pm eastern time on December 20, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its undersigned officer this 19th day of December, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
			<td colspan="3" style="vertical-align:middle;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">BIO-KEY INTERNATIONAL, INC. &nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:middle;width:1.6%;">&nbsp;</td>
			<td style="vertical-align:middle;width:19.8%;">&nbsp;</td>
			<td style="vertical-align:middle;width:5.3%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:middle;width:1.6%;">&nbsp;</td>
			<td style="vertical-align:middle;width:19.8%;">&nbsp;</td>
			<td style="vertical-align:middle;width:5.3%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:middle;width:1.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:19.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>/s/ Michael W. DePasquale</i></p>
			</td>
			<td style="vertical-align:middle;width:5.3%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:middle;width:1.6%;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:25.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name: Michael W. DePasquale &nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:middle;width:1.6%;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:25.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title: Chief Executive Officer</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex_607848.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>bkyi20231121_def14a.htm</title>

	<!-- Generated by ThunderDome Portal - 12/18/2023 11:47:00 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>BIO-KEY INTERNATIONAL, INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023 STOCK INCENTIVE PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<div style="display: none;">&nbsp;</div>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt; text-align: center;"><b>(Effective December 14, 2023)</b></p>

<div style="display: none;">&nbsp;</div>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Purpose of Plan</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The purpose of the BIO-key International, Inc. 2023 Stock Incentive Plan (this &#8220;Plan&#8221;) is to advance the interests of BIO-key International, Inc., a Delaware corporation (the &#8220;Company&#8221;), and its stockholders by enabling the Company and its Subsidiaries to attract and retain qualified individuals through opportunities for equity participation in the Company, and to reward those individuals who contribute to the achievement of the Company&#8217;s economic objectives. This Plan will become effective upon its approval by the Company&#8217;s stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">2.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Definitions</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The following terms will have the meanings set forth below, unless the context clearly otherwise requires. Terms defined elsewhere in this Plan will have the same meaning throughout this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.1.&nbsp; &nbsp; &#8220;<u>Adverse Action</u>&#8221; means any action or conduct by a Participant that the Committee, in its sole discretion, determines to be injurious, detrimental, prejudicial or adverse to the interests of the Company or any Subsidiary, including: (a) disclosing confidential information of the Company or any Subsidiary to any person not authorized by the Company or Subsidiary to receive it, (b) engaging, directly or indirectly, in any commercial activity that in the judgment of the Committee competes with the business of the Company or any Subsidiary or (c) interfering with the relationships of the Company or any Subsidiary and their respective Employees, independent contractors, customers, prospective customers and vendors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.2.&nbsp; &nbsp; &nbsp;&#8220;<u>Applicable Law</u>&#8221; means any applicable law, including without limitation, (a) provisions of the Code, the Securities Act, the Exchange Act and any rules or regulations thereunder; (b) corporate, securities, tax or other laws, statutes, rules, requirements or regulations, whether federal, state, local or foreign; and (c) rules of any securities exchange, national market system or automated quotation system on which the shares of Common Stock are listed, quoted or traded.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.3.&nbsp; &nbsp; &nbsp;&#8220;<u>Board</u>&#8221; means the Board of Directors of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.4.&nbsp; &nbsp; &#8220;<u>Broker Exercise Notice</u>&#8221; means a written notice pursuant to which a Participant, upon exercise of an Option, irrevocably instructs a broker or dealer to sell a sufficient number of shares of Common Stock or loan a sufficient amount of money to pay all or a portion of the exercise price of the Option and/or any related withholding tax obligations and remit such sums to the Company and directs the Company to deliver shares of Common Stock to be issued upon such exercise directly to such broker or dealer or their nominee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.5.&nbsp; &nbsp; &#8220;<u>Cause</u>&#8221; means (a) &#8220;Cause&#8221; as defined in any Individual Agreement; or (b) dishonesty, fraud, misrepresentation, embezzlement or other act of dishonesty with respect to the Company or any Subsidiary, (c) any unlawful or criminal activity of a serious nature, (d) any intentional and deliberate breach of a duty or duties that, individually or in the aggregate, are material in relation to the Participant&#8217;s overall duties, or (e) any material breach by a Participant of any employment, service, confidentiality or non-compete agreement entered into with the Company or any Subsidiary.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: justify;">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.6.&nbsp; &nbsp; &nbsp;&#8220;<u>Change in Control</u>&#8221; means an event described in Section 14.1 of this Plan; provided, however, if distribution of an Incentive Award subject to Section 409A of the Code is triggered by a Change in Control, the term Change in Control will mean a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the assets of the Company, as defined in Section 409A of the Code and the regulations and rulings issued thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.7.&nbsp; &nbsp; &nbsp;&#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code herein will be deemed to include a reference to any applicable regulations thereunder and any successor or amended section of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.8.&nbsp; &nbsp; &nbsp;&#8220;<u>Committee</u>&#8221; means the group of individuals administering this Plan, as provided in Section 3 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.9.&nbsp; &nbsp; &nbsp;&#8220;<u>Common Stock</u>&#8221; means the common stock of the Company, par value $0.0001 per share, or the number and kind of shares of stock or other securities into which such Common Stock may be changed in accordance with Section 4.4 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.10.&nbsp; &nbsp;&#8220;<u>Company</u>&#8221; means BIO-key International, Inc., a Delaware corporation, and any successor thereto as provided in Section 21.6 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.11.&nbsp; &nbsp;&#8220;<u>Deferred Stock Unit</u>&#8221; means a right granted to an Eligible Recipient pursuant to Section 8 of this Plan to receive shares of Common Stock (or the equivalent value in cash or other property if the Committee so provides) at a future time as determined by the Committee, or as determined by the Participant within guidelines established by the Committee in the case of voluntary deferral elections.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.12.&nbsp; &nbsp;&#8220;<u>Director</u>&#8221; means a member of the Board.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.13.&nbsp; &nbsp;&#8220;<u>Disability</u>&#8221; means, with respect to a Participant who is a party to an Individual Agreement, which agreement contains a definition of &#8220;disability&#8221; or &#8220;permanent disability&#8221; (or words of like import) for purposes of termination of employment thereunder by the Company, &#8220;disability&#8221; or &#8220;permanent disability&#8221; as defined in the most recent of such agreements; or in all other cases, means the disability of the Participant such as would entitle the Participant to receive disability income benefits pursuant to the long&#8209;term disability plan of the Company or Subsidiary then covering the Participant or, if no such plan exists or is applicable to the Participant, the permanent and total disability of the Participant within the meaning of Section 22(e)(3) of the Code; provided, however, if distribution of an Incentive Award subject to Section 409A of the Code is triggered by an Eligible Recipient&#8217;s Disability, such term will mean that the Eligible Recipient is disabled as defined by Section 409A of the Code and the regulations and rulings issued thereunder.</p>

<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.14.&nbsp; &nbsp;&#8220;<u>Dividend Equivalents</u>&#8221; means a credit, made at the discretion of the Committee, to the account of a Participant in an amount equal to the cash dividends paid on one share of Common Stock for each share of Common Stock represented by an Incentive Award held by such Participant, subject to Section 11 of this Plan and any other provision of this Plan and which Dividend Equivalents may be subject to the same conditions and restrictions as the Incentive Awards to which they attach and may be settled in the form of cash, shares of Common Stock, or in any combination of both.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.15.&nbsp; &nbsp;&#8220;<u>Effective Date</u>&#8221; means the date that this Plan is approved by the Company&#8217;s stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.16.&nbsp; &nbsp;&#8220;<u>Eligible Recipients</u>&#8221; means all Employees and consultants, advisors and independent contractors of the Company or any Subsidiary, including Non-Employee Directors; provided, however, that an Eligible Recipient shall not include any person engaged to provide consulting or advisory services (other than as an employee or a director) to the Company or any Subsidiary that are in connection with the offer and sale of the Company&#8217;s securities in a capital raising transaction or directly or indirectly promote or maintain a market for the Company&#8217;s securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.17.&nbsp; &nbsp;&#8220;<u>Employee</u>&#8221; means any individual performing services for the Company or a Subsidiary and designated as an employee of the Company or a Subsidiary on the payroll records thereof. An Employee will not include any individual during any period he or she is classified or treated by the Company or Subsidiary as an independent contractor, a consultant, or any employee of an employment, consulting or temporary agency or any other entity other than the Company or Subsidiary, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as a common-law employee of the Company or Subsidiary during such period. An individual will not cease to be an Employee in the case of: (a) any leave of absence approved by the Company, or (b) transfers between locations of the Company or between the Company or any Subsidiaries. For purposes of Incentive Stock Options, no such leave may exceed ninety (90) days, unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company or a Subsidiary, as applicable, is not so guaranteed, then three (3) months following the ninety-first (91st) day of such leave, any Incentive Stock Option held by a Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Non-Statutory Stock Option. Neither service as a Director nor payment of a Director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.18.&nbsp; &nbsp;&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended. Any reference to a section of the Exchange Act herein will be deemed to include a reference to any applicable rules and regulations thereunder and any successor or amended section of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.19.&nbsp; &nbsp;&#8220;<u>Fair Market Value</u>&#8221; means, with respect to the Common Stock, as of any date: (a) the mean between the reported high and low sale prices of the Common Stock as of such date during the regular daily trading session, as reported on the Nasdaq Global Select Market, Nasdaq Global Market, Nasdaq Capital Market, the New York Stock Exchange, NYSE American or any other national securities exchange on which the Common Stock is then listed or quoted (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote); or (b) if the Common Stock is not so listed, admitted to unlisted trading privileges, or reported on any national securities exchange, the mean between the reported high and low sale prices as of such date during the regular daily trading session, as reported by the OTC Bulletin Board, OTC Markets or other comparable quotation service (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote); or (c) if the Common Stock is not so listed or reported, such price as the Committee determines in good faith, and consistent with the definition of &#8220;fair market value&#8221; under Section 409A of the Code. If determined by the Committee, such determination will be final, conclusive and binding for all purposes and on all persons, including the Company, the stockholders of the Company, the Participants and their respective successors-in-interest. No member of the Committee will be liable for any determination regarding the fair market value of the Common Stock that is made in good faith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.20.&nbsp; &nbsp;&#8220;<u>Grant Date</u>&#8221; means the date an Incentive Award is granted to a Participant pursuant to this Plan and as determined pursuant to Section 5 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.21.&nbsp; &nbsp;&#8220;<u>Incentive Award</u>&#8221; means an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit, Deferred Stock Unit, Performance Award or Other Stock-Based Award granted to an Eligible Recipient pursuant to this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.22.&nbsp; &nbsp;&#8220;<u>Incentive Award Agreement</u>&#8221; means either: (a) a written or electronic agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Incentive Award granted under this Plan, including any amendment or modification thereof, or (b) a written or electronic statement issued by the Company to a Participant describing the terms and provisions of an Incentive Award, including any amendment or modification thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.23.&nbsp; &nbsp;&#8220;<u>Incentive Stock Option</u>&#8221; means a right to purchase shares of Common Stock granted to an Employee pursuant to Section 6 of this Plan that is designated as and intended to meet the requirements of an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.24.&nbsp; &nbsp;&#8220;<u>Individual Agreement</u>&#8221; means any employment, consulting, severance or similar agreement between the Participant and the Company or one of its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.25.&nbsp; &nbsp;&#8220;<u>Non-Employee Director</u>&#8221; means a Director who is not an Employee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.26.&nbsp; &nbsp;&#8220;<u>Non-Statutory Stock Option</u>&#8221; means a right to purchase shares of Common Stock granted to an Eligible Recipient pursuant to Section 6 of this Plan that does not qualify as an Incentive Stock Option.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.27.&nbsp; &nbsp;&#8220;<u>Option</u>&#8221; means an Incentive Stock Option or a Non&#8209;Statutory Stock Option.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.28.&nbsp; &nbsp;&#8220;<u>Other Stock-Based Award</u>&#8221; means an award of shares of Common Stock granted to an Eligible Recipient pursuant to Section 10 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.29.&nbsp; &nbsp;&#8220;<u>Participant</u>&#8221; means an Eligible Recipient who receives one or more Incentive Awards under this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.30.&nbsp; &nbsp;&#8220;<u>Performance Award</u>&#8221; means a right granted to an Eligible Recipient pursuant to Section 9 of this Plan to receive an amount of cash, a number of shares of Common Stock, or a combination of both, contingent upon and the value of which at the time it is payable is determined as a function of the extent of the achievement of one or more Performance Criteria during a specified performance period or the achievement of other objectives during a specified period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.31.&nbsp; &#8220;<u>Performance Criteria</u>&#8221; means the performance criteria that may be used by the Committee in granting Incentive Awards contingent upon achievement of performance goals, including, without limitation, net sales; operating income; income before income taxes; income before interest, taxes, depreciation and amortization; income before income taxes; income before interest, taxes, depreciation and amortization and other non-cash items; net income; net income per share (basic or diluted); profitability as measured by return ratios (including return on assets, return on equity, return on capital, return on investment and return on sales); cash flows; market share; cost of sales; sales, general and administrative expense, cost reduction goals; margins (including one or more of gross, operating and net income margins); stock price; total return to stockholders; economic value added; working capital and strategic plan development and implementation. The Committee may select one criterion or multiple criteria for measuring performance, and the measurement may be based upon Company, Subsidiary or business unit performance, either absolute or by relative comparison to prior periods or other companies or any other external measure of the selected criteria.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.32.&nbsp; &nbsp;&#8220;<u>Plan</u>&#8221; means the BIO-key International, Inc. 2023 Stock Incentive Plan, as may be amended from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.33.&nbsp; &nbsp;&#8220;<u>Previously Acquired Shares</u>&#8221; means shares of Common Stock that are already owned by the Participant or, with respect to any Incentive Award, that are to be issued to the Participant upon the grant, exercise, vesting or settlement of such Incentive Award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.34.&nbsp; &nbsp;&#8220;<u>Restricted Stock Award</u>&#8221; means an award of Common Stock granted to an Eligible Recipient pursuant to Section 8 of this Plan that is subject to the restrictions on transferability and the risk of forfeiture imposed by the provisions of such Section 8.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.35.&nbsp; &nbsp;&#8220;<u>Restricted Stock Unit</u>&#8221; means an award denominated in shares of Common Stock granted to an Eligible Recipient pursuant to Section 8 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.36.&nbsp; &nbsp;&#8220;<u>Retirement</u>&#8221; means termination of employment or service pursuant to and in accordance with the regular (or, if approved by the Board for purposes of this Plan, early) retirement/pension plan or practice of the Company or Subsidiary then covering the Participant, provided that if the Participant is not covered by any such plan or practice, the Participant will be deemed to be covered by the Company plan or practice for purposes of this determination/termination of employment or if the Company does not have any such retirement/pension plan or practice, service at age 55 or older and completion of at least 10 years of continuous service.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.37.&nbsp; &nbsp;&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended. Any reference to a section of the Securities Act herein will be deemed to include a reference to any applicable rules and regulations thereunder and any successor or amended section of the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.38.&nbsp; &nbsp;&#8220;<u>Separation from Service</u>&#8221; has the meaning set forth in Section 12.4(c) of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.39.&nbsp; &nbsp;&#8220;<u>Stock Appreciation Right</u>&#8221; means a right granted to an Eligible Recipient pursuant to Section 7 of this Plan to receive, upon exercise, a payment from the Company, in the form of shares of Common Stock, cash or a combination of both, equal to the difference between the Fair Market Value of one or more shares of Common Stock and the grant price of such shares under the terms of such Stock Appreciation Right.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.40.&nbsp; &nbsp;&#8220;<u>Subsidiary</u>&#8221; means any entity that is directly or indirectly controlled by the Company or any entity in which the Company has a significant equity interest, as determined by the Committee provided the Company has a &#8220;controlling interest&#8221; in the Subsidiary as defined in Treas. Reg. Sec. 1.409A-1(b)(5)(iii)(E)(1).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.41.&nbsp; &nbsp;&#8220;<u>Tax Date</u>&#8221; means the date any withholding or employment related tax obligation arises under the Code or any Applicable Law for a Participant with respect to an Incentive Award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">2.42.&nbsp; &nbsp;<u>Tax Laws</u>&#8221; has the meaning set forth in Section 21.10 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Plan Administration</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">3.1.&nbsp; &nbsp; <u>The Committee</u>. This Plan will be administered by the Board or by a committee of the Board. So long as the Company has a class of its equity securities registered under Section 12 of the Exchange Act, any committee administering this Plan will consist solely of two or more members of the Board who are &#8220;non&#8209;employee directors&#8221; within the meaning of Rule 16b&#8209;3 under the Exchange Act and who are &#8220;independent directors&#8221; under the Listing Rules of the Nasdaq Stock Market (or other applicable market or exchange on which the Company&#8217;s Common Stock may be quoted or traded). Such a committee, if established, will act by majority approval of the members (but may also take action by the written consent of all of the members of such committee), and a majority of the members of such a committee will constitute a quorum. As used in this Plan, &#8220;Committee&#8221; will refer to the Board or to such a committee, if established. To the extent consistent with applicable corporate law of the Company&#8217;s jurisdiction of incorporation, the Committee may delegate to any officers of the Company the duties, power and authority of the Committee under this Plan pursuant to such conditions or limitations as the Committee may establish; provided, however, that only the Committee may exercise such duties, power and authority with respect to Eligible Recipients who are subject to Section 16 of the Exchange Act. The Committee may exercise its duties, power and authority under this Plan in its sole and absolute discretion without the consent of any Participant or other party, unless this Plan specifically provides otherwise. Each determination, interpretation or other action made or taken by the Committee pursuant to the provisions of this Plan will be final, conclusive and binding for all purposes and on all persons, and no member of the Committee will be liable for any action or determination made in good faith with respect to this Plan or any Incentive Award granted under this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">3.2.&nbsp; &nbsp; &nbsp;<u>Authority of the Committee</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify; text-indent: 27pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;In accordance with and subject to the provisions of this Plan, the Committee will have full and exclusive discretionary power and authority to take such actions as it deems necessary and advisable with respect to the administration of this Plan, including the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 18pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;To designate the Eligible Recipients to be selected as Participants;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 18pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;To determine the nature, extent and terms of the Incentive Awards to be made to each Participant (including the number of shares of Common Stock to be subject to each Incentive Award, any exercise price or grant price, the manner in which Incentive Awards will vest, become exercisable, settled or paid out and whether Incentive Awards will be granted in tandem with other Incentive Awards) and the form of an Incentive Award Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;To determine the time or times when Incentive Awards will be granted;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;To determine the duration of each Incentive Award;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;To determine the terms, restrictions and other conditions to which the payment or vesting of Incentive Awards may be subject;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;To pay the economic value of any Incentive Award in the form of cash, Common Stock or any combination of both;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;To construe and interpret this Plan and Incentive Awards granted under it, and to establish, amend and revoke rules and regulations for its administration and in so doing, to correct any defect, omission, or inconsistency in this Plan or in an Incentive Award Agreement, in a manner and to the extent it will deem necessary or expedient to make this Plan fully effective;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;To determine Fair Market Value in accordance with Section 2.19 of this Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(ix)&nbsp;&nbsp;&nbsp;&nbsp;To amend this Plan or any Incentive Award Agreement, as provided in this Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp;To adopt subplans or special provisions applicable to Incentive Awards regulated by the laws of a jurisdiction other than, and outside of, the United States, which except as otherwise provided in this Plan, such subplans or special provisions may take precedence over other provisions of this Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(xi)&nbsp;&nbsp;&nbsp;&nbsp;To authorize any person to execute on behalf of the Company any Incentive Award Agreement or any other instrument required to effect the grant of an Incentive Award previously granted by the Committee;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(xii)&nbsp;&nbsp;&nbsp;&nbsp;To determine whether Incentive Awards will be settled in shares of Common Stock, cash or in any combination thereof;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;To determine whether Incentive Awards will be adjusted for Dividend Equivalents; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 63pt; text-indent: 18pt; text-align: justify;">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;To impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by a Participant or other subsequent transfers by the Participant of any shares of Common Stock, including restrictions under an insider trading policy, stock ownership guidelines, restrictions as to the use of a specified brokerage firm for such resales or other transfers and other restrictions designed to increase equity ownership by Participants or otherwise align the interests of Participants with the Company&#8217;s stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify; text-indent: 27pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section 3.2(d) of this Plan, the Committee will have the authority under this Plan to amend or modify the terms of any outstanding Incentive Award in any manner, including, without limitation, the authority to modify the number of shares of Common Stock or other terms and conditions of an Incentive Award, extend the term of an Incentive Award, accelerate the exercisability or vesting or otherwise terminate any restrictions relating to an Incentive Award, accept the surrender of any outstanding Incentive Award or, to the extent not previously exercised or vested, authorize the grant of new Incentive Awards in substitution for surrendered Incentive Awards; provided, however that the amended or modified terms are permitted by this Plan as then in effect and that any Participant adversely affected by such amended or modified terms has consented to such amendment or modification.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;In the event of (i) any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, extraordinary dividend or divestiture (including a spin&#8209;off) or any other similar change in corporate structure or shares; (ii) any purchase, acquisition, sale, disposition or write-down of a significant amount of assets or a significant business; (iii) any change in accounting principles or practices, tax laws or other such laws or provisions affecting reported results; (iv) any uninsured catastrophic losses or extraordinary non-recurring items as described in management&#8217;s discussion and analysis of financial performance appearing in the Company&#8217;s annual report to stockholders for the applicable year; or (v) any other similar change, in each case with respect to the Company or any other entity whose performance is relevant to the grant or vesting of an Incentive Award, the Committee (or, if the Company is not the surviving corporation in any such transaction, the board of directors of the surviving corporation) may, without the consent of any affected Participant, amend or modify the vesting criteria (including Performance Criteria) of any outstanding Incentive Award that is based in whole or in part on the financial performance of the Company (or any Subsidiary or division or other subunit thereof) or such other entity so as equitably to reflect such event, with the desired result that the criteria for evaluating such financial performance of the Company or such other entity will be substantially the same (in the sole discretion of the Committee or the board of directors of the surviving corporation) following such event as prior to such event; provided, however, that the amended or modified terms are permitted by this Plan as then in effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of this Plan other than Section 4.4 of this Plan, the Committee may not, without prior approval of the Company&#8217;s stockholders, seek to effect any re-pricing of any previously granted, &#8220;underwater&#8221; Option or Stock Appreciation Right by: (i) amending or modifying the terms of the Option or Stock Appreciation Right to lower the exercise price or grant price; (ii) canceling the underwater Option or Stock Appreciation Right in exchange for (A) cash; (B) replacement Options or Stock Appreciation Rights having a lower exercise price or grant price; or (C) other Incentive Awards; (iii) repurchasing the underwater Options or Stock Appreciation Rights and granting new Incentive Awards under this Plan; or (iv) a re-pricing within the meaning of the applicable accounting standard. For purposes of this Section 3.2(d), an Option or Stock Appreciation Right will be deemed to be &#8220;underwater&#8221; at any time when the Fair Market Value of the Common Stock is less than the exercise price of the Option or grant price of the Stock Appreciation Right.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;In addition to the authority of the Committee under Section 3.2(a) of this Plan and notwithstanding any other provision of this Plan, the Committee may, in its sole discretion, amend the terms of this Plan or Incentive Awards with respect to Participants resident outside of the United States or employed by a non-U.S. Subsidiary in order to comply with local legal requirements, to otherwise protect the Company&#8217;s or Subsidiary&#8217;s interests, or to meet objectives of this Plan, and may, where appropriate, establish one or more sub-plans (including the adoption of any required rules and regulations) for the purposes of qualifying for preferred tax treatment under foreign tax laws. The Committee will have no authority, however, to take action pursuant to this Section 3.2(e) of this Plan: (i) to reserve shares of Common Stock or grant Incentive Awards in excess of the limitations provided in Section 4.1 and Section 4.2 of this Plan; (ii) to effect any re-pricing in violation of Section 3.2(d) of this Plan; (iii) to grant Options or Stock Appreciation Rights having an exercise price or grant price less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date in violation of Section 6.2 or 7.2 of this Plan, as the case may be; or (iv) for which stockholder approval would then be required pursuant to Section 422 of the Code or the Listing Rules of the Nasdaq Stock Market (or other applicable market or exchange on which the Company&#8217;s Common Stock may be quoted or traded).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Shares Available for Issuance</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.1.&nbsp; &nbsp; &nbsp;<u>Maximum Number of Shares Available</u>. Subject to adjustment as provided in Section 4.4 of this Plan, the maximum number of shares of Common Stock that will be available for issuance under this Plan will be 6,000,000.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.2.&nbsp; &nbsp; &nbsp;<u>Incentive Award and Non-Employee Director Compensation Limitations</u>. Notwithstanding any other provisions of this Plan to the contrary and subject to adjustment as provided in Section 4.4 of this Plan,</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;the maximum aggregate number of shares of Common Stock that will be available for issuance pursuant to Incentive Stock Options under this Plan will be 6,000,000 shares (except in the case of Incentive Stock Options granted as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity pursuant to the applicable transaction terms);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;the maximum aggregate number of shares of Common Stock that will be available for issuance pursuant to Incentive Awards, other than Options or Stock Appreciation Rights, under this Plan will be 5,000,000 shares (except in the case of Incentive Awards granted as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity pursuant to the applicable transaction terms); and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;the sum of any cash compensation, or other compensation, and the value (determined as of the grant date in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or any successor thereto) of Incentive Awards granted to a Non-Employee Director as compensation for services as a Non-Employee Director during any fiscal year of the Company may not exceed $200,000 (increased to $300,000 with respect to any Non-Employee Director serving as Chairman of the Board or Lead Independent Director or in the fiscal year of a Non-Employee Director&#8217;s initial service as a Non-Employee Director) (with any compensation that is deferred counting towards this limit for the year in which the compensation is first earned, and not a later year of settlement).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.3.&nbsp; &nbsp; &nbsp;<u>Accounting for Incentive Awards</u>. Shares of Common Stock that are issued under this Plan or that are subject to outstanding Incentive Awards will be applied to reduce the maximum number of shares of Common Stock remaining available for issuance under this Plan only to the extent they are used; provided, however, that; (a) any shares which would have been issued upon any exercise of an Option but for the fact that the exercise price was paid by a &#8220;net exercise&#8221; pursuant to Section 6.4(b) of this Plan or the tender or attestation as to ownership of Previously Acquired Shares pursuant to Section 6.4(a) of this Plan will not again become available for issuance under this Plan; and (b) the full number of shares of Common Stock subject to a stock-settled Stock Appreciation Right will be counted against the shares of Common Stock authorized for issuance under this Plan, regardless of the number of shares of Common Stock actually issued upon settlement of such Stock Appreciation Right, and will not again become available for issuance under this Plan. Furthermore, any shares of Common Stock withheld to satisfy tax withholding obligations on Incentive Awards issued under this Plan, any shares of Common Stock withheld to pay the exercise price or grant price of Incentive Awards under this Plan and any shares of Common Stock not issued or delivered as a result of the &#8220;net exercise&#8221; of an outstanding Option pursuant to Section 6.4 or settlement of a Stock Appreciation Right in shares of Common Stock pursuant to Section 7.1 will be counted against the shares of Common Stock authorized for issuance under this Plan and will not be available again for grant under this Plan. Any shares of Common Stock repurchased by the Company on the open market using the proceeds from the exercise of an Incentive Award will not increase the number of shares of Common Stock available for future grant of Incentive Awards. Any shares of Common Stock related to Incentive Awards granted under this Plan that terminate by expiration, forfeiture, cancellation or otherwise without the issuance of the shares of Common Stock, or are settled in cash in lieu of shares of Common Stock, or are exchanged with the Committee&#8217;s permission, prior to the issuance of shares of Common Stock, for Incentive Awards not involving shares of Common Stock, will be available again for grant under this Plan and correspondingly increase the total number of shares of Common Stock available for issuance under this Plan under Section 4.1.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.4.&nbsp; &nbsp; <u>Adjustments to Shares and Incentive Awards</u>. In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin&#8209;off) or any other similar change in the corporate structure or shares of Common Stock of the Company, the Committee (or, if the Company is not the surviving corporation in any such transaction, the board of directors of the surviving corporation) will make appropriate adjustment or substitutions (which determination will be conclusive) as to the number and kind of securities or other property (including cash) available for issuance or payment under this Plan, including the sub-limits set forth in Section 4.2 of this Plan, and, in order to prevent dilution or enlargement of the rights of Participants, (a) the number and kind of securities or other property (including cash) subject to outstanding Incentive Awards, and (b) the exercise price of outstanding Options and Stock Appreciation Rights.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Participation</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Participants in this Plan will be those Eligible Recipients who, in the judgment of the Committee, have contributed, are contributing or are expected to contribute to the achievement of economic objectives of the Company or its Subsidiaries. Eligible Recipients may be granted from time to time one or more Incentive Awards, singly or in combination or in tandem with other Incentive Awards, as may be determined by the Committee in its sole discretion. Incentive Awards will be deemed to be granted as of the date specified in the grant resolution of the Committee, which date will be the date of any related agreement with the Participant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">6.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Options</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.1.&nbsp; &nbsp; &nbsp;<u>Grant</u>. An Eligible Recipient may be granted one or more Options under this Plan, and such Options will be subject to such terms and conditions, consistent with the other provisions of this Plan, as may be determined by the Committee in its sole discretion. Incentive Stock Options may be granted solely to Eligible Recipients who are Employees of the Company or a Subsidiary. The Committee may designate whether an Option is to be considered an Incentive Stock Option or a Non&#8209;Statutory Stock Option. To the extent that any Incentive Stock Option (or portion thereof) granted under this Plan ceases for any reason to qualify as an &#8220;incentive stock option&#8221; for purposes of Section 422 of the Code, such Incentive Stock Option (or portion thereof) will continue to be outstanding for purposes of this Plan but will thereafter be deemed to be a Non&#8209;Statutory Stock Option. Options may be granted to an Eligible Recipient for services provided to a Subsidiary only if, with respect to such Eligible Recipient, the underlying shares of Common Stock constitute &#8220;service recipient stock&#8221; within the meaning of Treas. Reg. Sec. 1.409A-1(b)(5)(iii) promulgated under the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.2.&nbsp; &nbsp; &nbsp; <u>Exercise Price</u>. The per share price to be paid by a Participant upon exercise of an Option granted pursuant to this Section 6 will be determined by the Committee in its sole discretion at the time of the Option grant; provided, however, that such price will not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date (or 110% of the Fair Market Value of one share of Common Stock on the Grant Date of an Incentive Stock Option if, at the time the Incentive Stock Option is granted, the Participant owns, directly or indirectly, more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary corporation of the Company). Notwithstanding the foregoing, to the extent that Options are granted under this Plan as a result of the Company&#8217;s assumption or substitution of options issued by any acquired, merged or consolidated entity, the exercise price for such Options shall be the price determined by the Committee pursuant to the conversion terms applicable to the transaction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.3.&nbsp; &nbsp; &nbsp;<u>Exercisability and Duration</u>. An Option will become exercisable at such times and in such installments and upon such terms and conditions as may be determined by the Committee in its sole discretion at the time of grant (including without limitation (a) the achievement of one or more of the Performance Criteria; and/or that (b) the Participant remain in the continuous employ or service of the Company or a Subsidiary for a certain period); provided, however, that no Option may be exercisable after 10 years from its Grant Date (five years from its Grant Date in the case of an Incentive Stock Option if, at the time the Incentive Stock Option is granted, the Participant owns, directly or indirectly, more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary corporation of the Company). Notwithstanding the foregoing, if the exercise of an Option that is exercisable in accordance with its terms is prevented by the provisions of Section 16 of this Plan, the Option will remain exercisable until thirty (30) days after the date such exercise first would no longer be prevented by such provisions, but in any event no later than the expiration date of such Option.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.4.&nbsp; &nbsp; &nbsp;<u>Payment of Exercise Price</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The total purchase price of the shares of Common Stock to be purchased upon exercise of an Option will be paid entirely in cash (including check, bank draft or money order); provided, however, that the Committee, in its sole discretion and upon terms and conditions established by the Committee, may allow such payments to be made, in whole or in part, by (i) tender of a Broker Exercise Notice; (ii) by tender, either by actual delivery or attestation as to ownership, of Previously Acquired Shares that are acceptable to the Committee; (iii) by a &#8220;net exercise&#8221; of the Option (as further described in paragraph (b), below); (iv) by a combination of such methods; or (v) by any other method approved or accepted by the Committee in its sole discretion. Notwithstanding any other provision of this Plan to the contrary, no Participant who is a Director or an &#8220;executive officer&#8221; of the Company within the meaning of Section 13(k) of the Exchange Act will be permitted to make payment with respect to any Incentive Awards granted under this Plan, or continue any extension of credit with respect to such payment with a loan from the Company or a loan arranged by the Company in violation of Section 13(k) of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the case of a &#8220;net exercise&#8221; of an Option, the Company will not require a payment of the exercise price of the Option from the Participant but will reduce the number of shares of Common Stock issued upon the exercise by the largest number of whole shares that has a Fair Market Value on the exercise date that does not exceed the aggregate exercise price for the shares exercised under this method. Shares of Common Stock will no longer be outstanding under an Option (and will therefore not thereafter be exercisable) following the exercise of such Option to the extent of (i) shares used to pay the exercise price of an Option under the &#8220;net exercise,&#8221; (ii) shares actually delivered to the Participant as a result of such exercise and (iii)&nbsp;any shares withheld for purposes of tax withholding pursuant to Section 13.1 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of such payment, Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value on the exercise date of the Option.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.5.&nbsp; &nbsp; &nbsp;<u>Manner of Exercise</u>. An Option may be exercised by a Participant in whole or in part from time to time, subject to the conditions contained in this Plan and in the Incentive Award Agreement evidencing such Option, by delivery in person, by facsimile or electronic transmission or through the mail of written notice of exercise to the Company at its principal executive office in Holmdel, New Jersey (or to the Company&#8217;s designee as may be established from time to time by the Company and communicated to Participants) and by paying in full the total exercise price for the shares of Common Stock to be purchased in accordance with Section 6.4 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.6.&nbsp; &nbsp; &nbsp;<u>Early Exercise</u>. An Option may, but need not, include a provision whereby the Participant may elect at any time before the Participant&#8217;s employment or service terminates to exercise the Option as to any part or all of the shares subject to the Option prior to the full vesting of the Option. Any unvested shares so purchased shall be subject to a repurchase option in favor of the Company and to any other restriction the Committee determines to be appropriate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">7.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Stock Appreciation Rights</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.1.&nbsp; &nbsp; &nbsp;<u>Grant</u>. An Eligible Recipient may be granted one or more Stock Appreciation Rights under this Plan, and such Stock Appreciation Rights will be subject to such terms and conditions, consistent with the other provisions of this Plan, as may be determined by the Committee in its sole discretion. The Committee will have the sole discretion to determine the form in which payment of the economic value of Stock Appreciation Rights will be made to a Participant (<i>i.e.</i>, cash, shares of Common Stock or any combination thereof) or to consent to or disapprove the election by a Participant of the form of such payment. Stock Appreciation Rights may be granted to an Eligible Recipient for services provided to a Subsidiary only if, with respect to such Eligible Recipient, the underlying shares of Common Stock constitute &#8220;service recipient stock&#8221; within the meaning of Treas. Reg. Sec. 1.409A-1(b)(5)(iii) promulgated under the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.2.&nbsp; &nbsp; &nbsp;<u>Grant Price</u>. The grant price of a Stock Appreciation Right will be determined by the Committee, in its discretion, at the Grant Date; provided, however, that such price may not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date, except as provided in Section 7.4 of this Plan. Notwithstanding the foregoing, to the extent that Stock Appreciation Rights are granted under this Plan as a result of the Company&#8217;s assumption or substitution of stock appreciation rights issued by any acquired, merged or consolidated entity, the grant price for such Stock Appreciation Rights shall be the price determined by the Committee pursuant to the conversion terms applicable to the transaction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.3.&nbsp; &nbsp; &nbsp;<u>Exercisability and Duration</u>. A Stock Appreciation Right will become exercisable at such times and in such installments as may be determined by the Committee in its sole discretion at the time of grant; provided, however, that no Stock Appreciation Right may be exercisable after 10 years from its Grant Date. A Stock Appreciation Right will be exercised by giving notice in the same manner as for Options, as set forth in Section 6.5 of this Plan. Notwithstanding the foregoing, if the exercise of a Stock Appreciation Right that is exercisable in accordance with its terms is prevented by the provisions of Section 16 of this Plan, the Stock Appreciation Right will remain exercisable until thirty (30) days after the date such exercise first would no longer be prevented by such provisions, but in any event no later than the expiration date of such Stock Appreciation Right.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.4.&nbsp; &nbsp; &nbsp;<u>Grants in Tandem with Options</u>. Stock Appreciation Rights may be granted alone or in addition to other Incentive Awards, or in tandem with an Option, either at the time of grant of the Option or at any time thereafter during the term of the Option. A Stock Appreciation Right granted in tandem with an Option shall cover the same number of shares of Common Stock as covered by the Option (or such lesser number as the Committee may determine), shall be exercisable at such time or times and only to the extent that the related Option is exercisable, have the same term as the Option and shall have a grant price equal to the exercise price for the Option. Upon the exercise of a Stock Appreciation Right granted in tandem with an Option, the Option shall be canceled automatically to the extent of the number of shares covered by such exercise; conversely, upon exercise of an Option having a related Stock Appreciation Right, the Stock Appreciation Right shall be canceled automatically to the extent of the number of shares covered by the Option exercise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">8.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Restricted Stock Awards, Restricted Stock Units and Deferred Stock Units</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.1.&nbsp; &nbsp; &nbsp;<u>Grant</u>. An Eligible Recipient may be granted one or more Restricted Stock Awards, Restricted Stock Units or Deferred Stock Units under this Plan, and such Incentive Awards will be subject to such terms and conditions, consistent with the other provisions of this Plan, as may be determined by the Committee in its sole discretion. Restricted Stock Units and Deferred Stock Units will be similar to Restricted Stock Awards except that no shares of Common Stock are actually awarded to the Participant on the Grant Date of the Restricted Stock Units. Restricted Stock Units and Deferred Stock Units will be denominated in shares of Common Stock but paid in cash, shares of Common Stock or a combination of cash and shares of Common Stock as the Committee, in its sole discretion, will determine, and as provided in the Incentive Award Agreement. The Committee may impose such restrictions or conditions, not inconsistent with the provisions of this Plan, to the vesting of such Restricted Stock Awards, Restricted Stock Units or Deferred Stock Units as it deems appropriate, including, without limitation, (a) the achievement of one or more of the Performance Criteria; and/or that (b) the Participant remain in the continuous employ or service of the Company or a Subsidiary for a certain period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.2.&nbsp; &nbsp; &nbsp;<u>Rights as a Stockholder; Transferability</u>. Except as provided in Sections 8.1, 8.3, 8.4 and 15.3 of this Plan, a Participant will have all voting, dividend, liquidation and other rights with respect to shares of Common Stock issued to the Participant as a Restricted Stock Award under this Section 8 upon the Participant becoming the holder of record of such shares as if such Participant were a holder of record of shares of unrestricted Common Stock. A Participant will have no voting rights to any Restricted Stock Units or Deferred Stock Units granted hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.3.&nbsp; &nbsp; &nbsp;<u>Dividends and Distributions</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Unless the Committee determines otherwise in its sole discretion (either in an Incentive Award Agreement at the time of grant or at any time after the grant of the Restricted Stock Award), any dividends or distributions (including regular quarterly cash dividends) paid with respect to shares of Common Stock subject to the unvested portion of a Restricted Stock Award will be subject to the same restrictions as the shares to which such dividends or distributions relate. In the event the Committee determines not to pay such dividends or distributions currently, the Committee will determine in its sole discretion whether any interest will be paid on such dividends or distributions. In addition, the Committee in its sole discretion may require such dividends and distributions to be reinvested (and in such case the Participants consent to such reinvestment) in shares of Common Stock that will be subject to the same restrictions as the shares to which such dividends or distributions relate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Unless the Committee determines otherwise in its sole discretion (either in a Participant&#8217;s Incentive Award Agreement or at any time after the grant of the Restricted Stock Unit or Deferred Stock Unit), to the extent permitted or required by Applicable Law, as determined by the Committee, prior to settlement or forfeiture, any Restricted Stock Units or Deferred Stock Units awarded under this Plan may, at the Committee&#8217;s discretion, carry with it a right to Dividend Equivalents. Such right entitles the Participant to be credited with an amount equal to all cash dividends paid on one share of Common Stock while the Restricted Stock Unit or Deferred Stock Unit is outstanding. Dividend Equivalents may be converted into additional Restricted Stock Units or Deferred Stock Units and may (and will, to the extent required below) be made subject to the same conditions and restrictions as the Restricted Stock Units or Deferred Stock Units to which they attach. Settlement of Dividend Equivalents may be made in the form of cash, in the form of shares of Common Stock, or in a combination of both. Dividend Equivalents as to Restricted Stock Units or Deferred Stock Units will be subject to forfeiture and termination to the same extent as the corresponding Restricted Stock Units or Deferred Stock Units as to which the Dividend Equivalents relate. In no event will Participants holding Restricted Stock Units or Deferred Stock Units be entitled to receive any Dividend Equivalents on such Restricted Stock Units or Deferred Stock Units until the vesting provisions of such Restricted Stock Units or Deferred Stock Units lapse.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.4.&nbsp; &nbsp; <u>Enforcement of Restrictions on Restricted Stock Awards</u>. To enforce the restrictions referred to in this Section 8, the Committee may place a legend on the stock certificates or book-entry notations representing Restricted Stock Awards referring to such restrictions and may require the Participant, until the restrictions have lapsed, to keep the stock certificates, together with duly endorsed stock powers, in the custody of the Company or its transfer agent, or to maintain evidence of stock ownership, together with duly endorsed stock powers, in a certificateless book&#8209;entry stock account with the Company&#8217;s transfer agent. Alternatively, Restricted Stock Awards may be held in non-certificated form pursuant to such terms and conditions as the Company may establish with its registrar and transfer agent or any third-party administrator designated by the Company to hold Restricted Stock Awards on behalf of Participants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">9.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Performance Awards</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">An Eligible Recipient may be granted one or more Performance Awards under this Plan, and such Performance Awards will be subject to such terms and conditions, if any, consistent with the other provisions of this Plan, as may be determined by the Committee in its sole discretion, including, but not limited to, the achievement of one or more of the Performance Criteria; provided, however, that in all cases payment of the Performance Award will be made within two and one-half months following the end of the Eligible Recipient&#8217;s tax year during which receipt of the Performance Award is no longer subject to a &#8220;substantial risk of forfeiture&#8221; within the meaning of Section 409A of the Code, except to the extent an Eligible Recipient has properly elected to defer the income that may be attributable to a Performance Award under a Company or Subsidiary deferred compensation plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">10.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Other Stock-Based Awards</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">An Eligible Recipient may be granted one or more Other Stock-Based Awards under this Plan, and such Other-Stock Based Awards will be subject to such terms and conditions, consistent with the other provisions of this Plan, as may be determined by the Committee in its sole discretion, not otherwise described by the terms of this Plan (including the grant or offer for sale of unrestricted shares of Common Stock) in such amounts and subject to such terms and conditions as the Committee will determine. Such Other-Stock Based Awards may involve the transfer of actual shares of Common Stock to Participants as a bonus or in lieu of obligations to pay cash or deliver other property under this Plan or under other plans or compensatory arrangements, or payment in cash or otherwise of amounts based on the value of shares of Common Stock, and may include Incentive Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States; provided, however, that in all cases payment of the Other Stock-Based Award will be made within two and one-half months following the end of the Eligible Recipient&#8217;s tax year during which receipt of the Other Stock-Based Award is no longer subject to a &#8220;substantial risk of forfeiture&#8221; within the meaning of Section 409A of the Code, except to the extent an Eligible Recipient has properly elected to defer the income that may be attributable to an Other Stock-Based Award under a Company or Subsidiary deferred compensation plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">11.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Dividend Equivalents</u></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Subject to the provisions of this Plan and any Incentive Award Agreement, any Participant selected by the Committee may be granted Dividend Equivalents based on the dividends declared on shares of Common Stock that are subject to any Incentive Award (including any Award that has been deferred), to be credited as of dividend payment dates, during the period between the date the Incentive Award is granted and the date the Incentive Award is exercised, vests, settles, is paid or expires, as determined by the Committee. Such Dividend Equivalents will be converted to cash or additional shares of Common Stock by such formula and at such time and subject to such limitations as may be determined by the Committee and the Committee may provide that such amounts (if any) will be deemed to have been reinvested in additional shares of Common Stock or otherwise reinvested. Notwithstanding the foregoing, the Committee may not grant Dividend Equivalents based on the dividends declared on shares of Common Stock that are subject to an Option or Stock Appreciation Right or unvested Performance Awards; and further, no dividends or Dividend Equivalents will be paid out with respect to any Incentive Awards until they are vested.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">12.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Effect of Termination of Employment or Other Service</u>. The following provisions shall apply upon termination of a Participant&#8217;s employment or other service with the Company and all Subsidiaries, unless otherwise expressly provided by the Committee in its sole discretion in an Incentive Award Agreement or the terms of an Individual Agreement or determined by the Committee pursuant to Section 12.3 of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.1.&nbsp; &nbsp; <u>Termination Due to Death, Disability or Retirement</u>. In the event a Participant&#8217;s employment or other service with the Company and all Subsidiaries is terminated by reason of death, Disability or Retirement:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;All outstanding Options and Stock Appreciation Rights then held by the Participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of twelve (12) months after such termination (but in no event after the expiration date of any such Option or Stock Appreciation Right). Options and Stock Appreciation Rights not exercisable as of such termination will be forfeited and terminate;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;All Restricted Stock Awards then held by the Participant that have not vested as of such termination will be terminated and forfeited; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;All outstanding but unpaid and non-vested Restricted Stock Units, Deferred Stock Units, Performance Awards and Other Stock-Based Awards then held by the Participant will be terminated and forfeited.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.2.&nbsp; &nbsp;<u>Termination for Reasons Other than Death, Disability or Retirement</u>. In the event a Participant&#8217;s employment or other service is terminated with the Company and all Subsidiaries for any reason other than death, Disability or Retirement, or a Participant is in the employ or service of a Subsidiary and the Subsidiary ceases to be a Subsidiary of the Company (unless the Participant continues in the employ or service of the Company or another Subsidiary):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;All outstanding Options and Stock Appreciation Rights then held by the Participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of three (3) months after such termination (but in no event after the expiration date of any such Option or Stock Appreciation Right). Options and Stock Appreciation Rights not exercisable as of such termination will be forfeited and terminate;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;All Restricted Stock Awards then held by the Participant that have not vested as of such termination will be terminated and forfeited; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;All outstanding but unpaid and non-vested Restricted Stock Units, Deferred Stock Units, Performance Awards and Other Stock-Based Awards then held by the Participant will be terminated and forfeited.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.3.&nbsp; &nbsp;<u>Modification of Rights Upon Termination</u>. Notwithstanding the other provisions of this Section 12, and subject to the terms of an Individual Agreement, upon a Participant&#8217;s termination of employment or other service with the Company or any Subsidiary, as the case may be, the Committee may, in its sole discretion (which may be exercised at any time on or after the Grant Date, including following such termination), except as provided in clause (ii), below, cause Options or Stock Appreciation Rights (or any part thereof) then by such Participant as of the effective date of such termination to terminate, become or continue to become exercisable and/or remain exercisable following such termination of employment or service (but not beyond the earlier of the original maximum term of such Option or Stock Appreciation Right or ten (10) years from the original Grant Date of such Option or Stock Appreciation Right), and Restricted Stock Awards, Restricted Stock Units, Deferred Stock Units, Performance Awards or Other Stock-Based Awards held by such Participant as of the effective date of such termination to terminate, vest and/or continue to vest or become free of restrictions and conditions to payment, as the case may be, following such termination of employment or service, in each case in the manner determined by the Committee; provided, however, that no Option or Stock Appreciation Right may remain exercisable beyond its expiration date; and (ii) any such action by the Committee adversely affecting any outstanding Incentive Award will not be effective without the consent of the affected Participant (subject to the right of the Committee to take whatever action it deems appropriate under Sections 3.2(c), 4.4 and 14 of this Plan).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.4.&nbsp; &nbsp; <u>Determination of Termination of Employment or Other Service</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The change in a Participant&#8217;s status from that of an Employee of the Company or any Subsidiary to that of a non-employee consultant, Director or advisor of the Company or any Subsidiary will, for purposes of this Plan, be deemed to result in a termination of such Participant&#8217;s employment with the Company and its Subsidiaries, unless the Committee otherwise determines in its sole discretion.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The change in a Participant&#8217;s status from that of a non-employee consultant, Director or advisor of the Company or any Subsidiary to that of an Employee of the Company or any Subsidiary will not, for purposes of this Plan, be deemed to result in a termination of such Participant&#8217;s service as a non-employee consultant, Director or advisor with the Company and its Subsidiaries, and such Participant will thereafter be deemed to be an Employee of the Company or its Subsidiaries until such Participant&#8217;s employment or service is terminated, in which event such Participant will be governed by the provisions of this Plan relating to termination of employment or service (subject to paragraph (a), above).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Unless the Committee otherwise determines in its sole discretion, a Participant&#8217;s employment or other service will, for purposes of this Plan, be deemed to have terminated on the date recorded on the personnel or other records of the Company or the Subsidiary for which the Participant provides employment or other service, as determined by the Committee in its sole discretion based upon such records; provided, however, if distribution or forfeiture of an Incentive Award subject to Section 409A of the Code is triggered by a termination of a Participant&#8217;s employment or other service, such termination must also constitute a &#8220;separation from service&#8221; within the meaning of Section 409A of the Code (a &#8220;Separation from Service&#8221;) and a Separation from Service shall constitute a termination of employment or other service.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.5.&nbsp; &nbsp;<u>Effect of Actions Constituting Cause or Adverse Action</u>. Notwithstanding anything in this Plan to the contrary and in addition to the other rights of the Committee under this Plan, including this Section 12, and subject to the terms of an Individual Agreement, if a Participant is determined by the Committee, acting in its sole discretion, to have taken any action that would constitute Cause or an Adverse Action during or within one (1) year after the termination of employment or other service with the Company or a Subsidiary, irrespective of whether such action or the Committee&#8217;s determination occurs before or after termination of such Participant&#8217;s employment or other service with the Company or any Subsidiary and irrespective of whether or not the Participant was terminated as a result of such Cause or Adverse Action, (a) all rights of the Participant under this Plan and any Incentive Award Agreements then held by the Participant will terminate and be forfeited without notice of any kind, and (b) the Committee in its sole discretion will have the authority to rescind the exercise, vesting or issuance of, or payment in respect of, any Incentive Awards of the Participant that were exercised, vested or issued, or as to which such payment was made, and to require the Participant to pay to the Company, within ten (10) days of receipt from the Company of notice of such rescission, any amount received or the amount of any gain realized as a result of such rescinded exercise, vesting, issuance or payment (including any dividends paid or other distributions made with respect to any shares of Common Stock subject to any Incentive Award). The Company may defer the exercise of any Option or Stock Appreciation Right for a period of up to six (6) months after receipt of the Participant&#8217;s written notice of exercise or the issuance of stock certificates or book-entry notations upon the vesting of any Incentive Award for a period of up to six (6) months after the date of such vesting in order for the Committee to make any determination as to the existence of Cause or an Adverse Action. The Company will be entitled to withhold and deduct from future wages of the Participant (or from other amounts that may be due and owing to the Participant from the Company or a Subsidiary) or make other arrangements for the collection of all amounts necessary to satisfy such payment obligations. Unless otherwise provided by the Committee in an Incentive Award Agreement, this Section 12.5 will not apply to any Participant following a Change in Control.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.6.&nbsp; &nbsp;<u>Forfeiture of Incentive Awards</u>. Subject to the terms of an Incentive Award Agreement, Incentive Awards under the Plan shall be subject to any automatic forfeiture or voluntary compensation &#8220;clawback,&#8221; forfeiture or recoupment provisions under Applicable Law and any compensation &#8220;clawback,&#8221; forfeiture or recoupment policy of the Company, as in effect from time to time, and such forfeiture and/or penalty conditions or provisions as determined by the Committee and set forth in the applicable Incentive Award Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">13.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Payment of Withholding Taxes</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">13.1.&nbsp; &nbsp;<u>General Rules</u>. The Company is entitled to (a) withhold and deduct from future wages of the Participant (or from other amounts that may be due and owing to the Participant from the Company or a Subsidiary), or make other arrangements for the collection of, all legally required amounts the Company reasonably determines are necessary to satisfy any and all federal, foreign, state and local withholding and employment&#8209;related tax requirements attributable to an Incentive Award, including, without limitation, the grant, exercise, vesting or settlement of, or payment of dividends with respect to, an Incentive Award or a disqualifying disposition of stock received upon exercise of an Incentive Stock Option; (b) withhold cash paid or payable or shares of Common Stock from the shares issued or otherwise issuable to the Participant in connection with an Incentive Award; or (c) require the Participant promptly to remit the amount of such withholding to the Company before taking any action, including issuing any shares of Common Stock, with respect to an Incentive Award. Shares of Common Stock issued or otherwise issuable to the Participant in connection with an Incentive Award that gives rise to tax withholding obligations that are withheld for purposes of satisfying the Participant&#8217;s withholding or employment-related tax obligation will be valued at their Fair Market Value on the Tax Date. When withholding shares of Common Stock for taxes is effected under this Plan, it will be withheld only up to an amount based on the maximum statutory tax rates in the Participant&#8217;s applicable tax jurisdictions or such other rate that will not trigger a negative accounting impact on the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">13.2.&nbsp; &nbsp;<u>Special Rules</u>. The Committee may, in its sole discretion and upon terms and conditions established by the Committee, permit or require a Participant to satisfy, in whole or in part, any withholding or employment&#8209;related tax obligation described in Section 13.1 of this Plan by withholding shares of Common Stock underlying an Incentive Award, by electing to tender, or by attestation as to ownership of, Previously Acquired Shares, by delivery of a Broker Exercise Notice or a combination of such methods. For purposes of satisfying a Participant&#8217;s withholding or employment-related tax obligation, shares of Common Stock withheld by the Company or Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value on the Tax Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">14.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Change in Control</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.1.&nbsp; &nbsp;<u>Definition of Change in Control</u>. Unless otherwise provided in an Incentive Award Agreement or Individual Agreement, a &#8220;Change in Control&#8221; shall be deemed to have occurred if the event set forth in any one of the following clauses shall have occurred. For purposes of this Section 14.1, a &#8220;Change in Control&#8221; of the Company will mean (a) the sale, lease, exchange or other transfer of substantially all of the assets of the Company (in one transaction or in a series of related transaction) to a person or entity that is not controlled, directly or indirectly, by the Company, (b) a merger or consolidation to which the Company is a party if the stockholders of the Company immediately prior to effective date of such merger or consolidation do not have &#8220;beneficial ownership&#8221; (as defined in Rule 13d-3 under the Exchange Act) immediately following the effective date of such merger or consolidation of more than 50% of the combined voting power of the surviving corporation&#8217;s outstanding securities ordinarily having the right to vote at elections of directors, or (c) a change in control of the Company of a nature that would be required to be reported pursuant to Section 13 or 15(d)<i> </i>of the Exchange Act, whether or not the Company is then subject to such reporting requirements, including, without limitation, such time as (i) any person becomes, after the effective date of this Plan, the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 40% or more of the combined voting power of the Company&#8217;s outstanding securities ordinarily having the right to vote at elections of directors, or (ii) individuals who constitute the Board on the effective date of this Plan cease for any reason to constitute at least a majority of the Board, provided that any person becoming a Director subsequent to the effective date of this Plan whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a majority of the Directors comprising the Board on the effective date of this Plan will, for purposes of this clause (ii), be considered as though such persons were a member of the Board on the Effective Date of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.2.&nbsp; &nbsp;<u>Acceleration of Vesting</u>. Without limiting the authority of the Committee under Sections 3.2 and 4.4 of this Plan, if a Change in Control of the Company occurs, then, if approved by the Committee in its sole discretion either in an Incentive Award Agreement at the time of grant or at any time after the grant of an Incentive Award: (a) all outstanding Options and Stock Appreciation Rights will become immediately exercisable in full and will remain exercisable in accordance with their terms, regardless of whether the Participants to whom such Options or Stock Appreciation Rights have been granted remain in the employ or service of the Company or any Subsidiary; (b) all outstanding Restricted Stock Awards will become immediately fully vested and non&#8209;forfeitable; and (c) all outstanding Restricted Stock Units, Deferred Stock Units, Performance Awards and Other Stock-Based Awards then held by the Participant will vest and/or continue to vest in the manner determined by the Committee and set forth in the Incentive Award Agreement evidencing such Restricted Stock Units, Deferred Stock Units, Performance Awards and Other Stock-Based Awards.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.3.&nbsp; &nbsp;<u>Cash Payment</u>. In connection with a Change in Control, the Committee in its sole discretion, either in an Incentive Award Agreement at the time of grant of an Incentive Award or at any time after the grant of such an Incentive Award, may determine that any or all outstanding Incentive Awards granted under the Plan, whether or not exercisable or vested, as the case may be, will be canceled and terminated and that in connection with such cancellation and termination the holder of such Incentive Award will receive for each share of Common Stock subject to such Incentive Award a cash payment (or the delivery of shares of stock, other securities or a combination of cash, stock and securities with a fair market value (as determined by the Committee in good faith) equivalent to such cash payment) equal to the difference, if any, between the consideration received by stockholders of the Company in respect of a share of Common Stock in connection with such Change in Control and the purchase price per share, if any, under the Incentive Award, multiplied by the number of shares of Common Stock subject to such Incentive Award (or in which such Incentive Award is denominated); provided, however, that if such product is zero ($0) or less or to the extent that the Incentive Award is not then exercisable, the Incentive Award may be canceled and terminated without payment therefor. If any portion of the consideration pursuant to a Change in Control may be received by holders of shares of Common Stock on a contingent or delayed basis, the Committee may, in its sole discretion, determine the fair market value per share of such consideration as of the time of the Change in Control on the basis of the Committee&#8217;s good faith estimate of the present value of the probable future payment of such consideration. Notwithstanding the foregoing, any shares of Common Stock issued pursuant to an Incentive Award that immediately prior to the effectiveness of the Change in Control are subject to no further restrictions pursuant to the Plan or an Incentive Award Agreement (other than pursuant to the securities laws) will be deemed to be outstanding shares of Common Stock and receive the same consideration as other outstanding shares of Common Stock in connection with the Change in Control.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.4.&nbsp; &nbsp;<u>Limitation on Change in Control</u> <u>Payments</u>. Notwithstanding anything in Section&nbsp;14.2 or 14.3 of this Plan to the contrary, if, with respect to a Participant, the acceleration of the vesting of an Incentive Award as provided in Section&nbsp;14.2 of this Plan or the payment of cash in exchange for all or part of an Incentive Award as provided in Section 14.3 of this Plan (which acceleration or payment could be deemed a &#8220;payment&#8221; within the meaning of Section&nbsp;280G(b)(2) of the Code), together with any other &#8220;payments&#8221; that such Participant has the right to receive from the Company or any corporation that is a member of an &#8220;affiliated group&#8221; (as defined in Section&nbsp;1504(a) of the Code without regard to Section&nbsp;1504(b) of the Code) of which the Company is a member, would constitute a &#8220;parachute payment&#8221; (as defined in Section&nbsp;280G(b)(2) of the Code), then the &#8220;payments&#8221; to such Participant pursuant to Section 14.2 or 14.3 of this Plan will be reduced (or acceleration of vesting eliminated) to the largest amount as will result in no portion of such &#8220;payments&#8221; being subject to the excise tax imposed by Section 4999 of the Code; provided, however, that such reduction will be made only if the aggregate amount of the payments after such reduction exceeds the difference between (A) the amount of such payments absent such reduction minus (B) the aggregate amount of the excise tax imposed under Section 4999 of the Code attributable to any such excess parachute payments; and provided, further, that such payments will be reduced (or acceleration of vesting eliminated) by first reducing or eliminating payments or benefits the full value of which are required to be recognized as contingent upon a Change in Control (determined in accordance with Treasury Regulation &#167; 1.280G-1, Q/A-24), followed by reducing or eliminating payments or benefits which are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from such date. Notwithstanding the foregoing sentence, if a Participant is subject to a separate agreement with the Company or a Subsidiary that expressly addresses the potential application of Sections 280G or 4999 of the Code, then this Section 14.4 will not apply, and any &#8220;payments&#8221; to a Participant pursuant to Section 14.2 or 14.3 of this Plan will be treated as &#8220;payments&#8221; arising under such separate agreement; provided, however, such separate agreement may not modify the time or form of payment under any Award that constitutes deferred compensation subject to Section 409A of the Code if the modification would cause such Incentive Award to become subject to the adverse tax consequences specified in Section 409A of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">15.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Rights of Eligible Recipients and Participants; Transferability</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.1.&nbsp; &nbsp;<u>Employment or Service</u>. Nothing in this Plan or an Incentive Award Agreement will interfere with or limit in any way the right of the Company or any Subsidiary to terminate the employment or service of any Eligible Recipient or Participant at any time, nor confer upon any Eligible Recipient or Participant any right to continue employment or other service with the Company or any Subsidiary.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.2.&nbsp; &nbsp; <u>No Rights to Incentive Awards</u>. Subject to the terms of an Individual Agreement, no Participant or Eligible Recipient will have any claim to be granted any Incentive Award under this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.3.&nbsp; &nbsp;<u>Rights as a Stockholder</u>. As a holder of Incentive Awards (other than Restricted Stock Awards), a Participant will have no rights as a stockholder unless and until such Incentive Awards are exercised for, or paid in the form of, shares of Common Stock and the Participant becomes the holder of record of such shares. Except as otherwise provided in this Plan or otherwise provided by the Committee, no adjustment will be made in the amount of cash payable or in the number of shares of Common Stock issuable under Incentive Awards denominated in or based on the value of shares of Common Stock as a result of cash dividends or distributions paid to holders of Common Stock prior to the payment of, or issuance of shares of Common Stock under, such Incentive Awards.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.4.&nbsp; &nbsp;<u>Restrictions on Transfer</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except pursuant to testamentary will or the laws of descent and distribution or as otherwise expressly permitted by subsections (b) and (c) below, no right or interest of any Participant in an Incentive Award prior to the exercise (in the case of Options) or vesting or issuance (in the case of Restricted Stock Awards, Restricted Stock Units, Deferred Stock Units, Performance Awards and Other Stock-Based Awards) of such Incentive Award will be assignable or transferable, or subjected to any lien, during the lifetime of the Participant, either voluntarily or involuntarily, directly or indirectly, by operation of law or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;A Participant will be entitled to designate a beneficiary to receive an Incentive Award upon such Participant&#8217;s death, and in the event of such Participant&#8217;s death, payment of any amounts due under this Plan will be made to, and exercise of any Options or Stock Appreciation Rights (to the extent permitted pursuant to Section 12 of this Plan) may be made by, such beneficiary. If a deceased Participant has failed to designate a beneficiary, or if a beneficiary designated by the Participant fails to survive the Participant, payment of any amounts due under this Plan will be made to, and exercise of any Options or Stock Appreciation Rights (to the extent permitted pursuant to Section 12 of this Plan) may be made by, the Participant&#8217;s legal representatives, heirs and legatees. If a deceased Participant has designated a beneficiary and such beneficiary survives the Participant but dies before complete payment of all amounts due under this Plan or exercise of all exercisable Options or Stock Appreciation Rights, then such payments will be made to, and the exercise of such Options or Stock Appreciation Rights may be made by, the legal representatives, heirs and legatees of the beneficiary.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Upon a Participant&#8217;s request, the Committee may, in its sole discretion, permit a transfer of all or a portion of a Non-Statutory Stock Option, other than for value, to such Participant&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, any person sharing such Participant&#8217;s household (other than a tenant or employee), a trust in which any of the foregoing have more than fifty percent (50%) of the beneficial interests, a foundation in which any of the foregoing (or the Participant) control the management of assets, and any other entity in which these persons (or the Participant) own more than fifty percent (50%) of the voting interests. Any permitted transferee will remain subject to all the terms and conditions applicable to the Participant prior to the transfer. A permitted transfer may be conditioned upon such requirements as the Committee may, in its sole discretion, determine, including, but not limited to execution and/or delivery of appropriate acknowledgements, opinion of counsel, or other documents by the transferee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Committee may impose such restrictions on any shares of Common Stock acquired by a Participant under this Plan as it may deem advisable, including minimum holding period requirements, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which the Common Stock is then listed or traded, or under any blue sky or state securities laws applicable to such shares or the Company&#8217;s insider trading policy.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.5.&nbsp; &nbsp;<u>Non-Exclusivity of this Plan</u>. Nothing contained in this Plan is intended to modify or rescind any previously approved compensation plans or programs of the Company or create any limitations on the power or authority of the Board to adopt such additional or other compensation arrangements as the Board may deem necessary or desirable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">16.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Securities Law and Other Restrictions</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding any other provision of this Plan or any Incentive Award Agreements entered into pursuant to this Plan, the Company will not be required to issue any shares of Common Stock under this Plan, and a Participant may not sell, assign, transfer or otherwise dispose of shares of Common Stock issued pursuant to Incentive Awards granted under this Plan, unless (a) there is in effect with respect to such shares a registration statement under the Securities Act and any applicable securities laws of a state or foreign jurisdiction or an exemption from such registration under the Securities Act and applicable state or foreign securities laws, and (b) there has been obtained any other consent, approval or permit from any other U.S. or foreign regulatory body which the Committee, in its sole discretion, deems necessary or advisable. The Company may condition such issuance, sale or transfer upon the receipt of any representations or agreements from the parties involved, and the placement of any legends on certificates or book-entry notations representing shares of Common Stock, as may be deemed necessary or advisable by the Company in order to comply with such securities law or other restrictions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">17.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Deferred Compensation; Compliance with Section 409A</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">It is intended that all Incentive Awards issued under this Plan be in a form and administered in a manner that will comply with the requirements of Section 409A of the Code, or the requirements of an exception to Section 409A of the Code, and the Incentive Award Agreements and this Plan will be construed and administered in a manner that is consistent with and gives effect to such intent. The Committee is authorized to adopt rules or regulations deemed necessary or appropriate to qualify for an exception from or to comply with the requirements of Section 409A of the Code. With respect to an Incentive Award that constitutes a deferral of compensation subject to Code Section 409A: (a) if any amount is payable or forfeited under such Incentive Award upon a termination of service, a termination of service will be treated as having occurred only at such time the Participant has experienced a Separation from Service; (b) if any amount is payable under such Incentive Award upon a Disability, a Disability will be treated as having occurred only at such time the Participant has experienced a &#8220;disability&#8221; as such term is defined for purposes of Code Section 409A; (c) if any amount is payable under such Incentive Award on account of the occurrence of a Change in Control, a Change in Control will be treated as having occurred only at such time a &#8220;change in the ownership or effective control of the corporation or in the ownership of a substantial portion of the assets of the corporation&#8221; as such terms are defined for purposes of Code Section 409A, (d) if any amount becomes payable under such Incentive Award on account of a Participant&#8217;s Separation from Service at such time as the Participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A, then no payment will be made, except as permitted under Code Section 409A, prior to the first business day after the earlier of (i) the date that is six (6) months after the date of the Participant&#8217;s Separation from Service or (ii) the Participant&#8217;s death, and (e) no amendment to or payment under such Incentive Award, including by way of an Individual Agreement, will be made except and only to the extent permitted under Code Section 409A.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">18.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Plan Amendment, Modification and Termination</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Board may suspend or terminate this Plan or any portion thereof at any time. In addition to the authority of the Committee to amend this Plan under Section 3.2(e) of this Plan, the Board may amend this Plan from time to time in such respects as the Board may deem advisable in order that Incentive Awards under this Plan will conform to any change in Applicable Laws or regulations or in any other respect the Board may deem to be in the best interests of the Company; provided, however, that no such amendments to this Plan will be effective without approval of the Company&#8217;s stockholders if: (i) stockholder approval of the amendment is then required pursuant to Section 422 of the Code or the Listing Rules of the Nasdaq Stock Market (or other applicable market or exchange on which the Company&#8217;s Common Stock may be quoted or traded); or (ii) such amendment seeks to increase the number of shares authorized for issuance hereunder (other than by virtue of an adjustment under Section 4.4 of this Plan) or to modify Section 3.2(d) of this Plan. No termination, suspension or amendment of this Plan may adversely affect any outstanding Incentive Award without the consent of the affected Participant; provided, however, that this sentence will not impair the right of the Committee to take whatever action it deems appropriate under Sections 3.2(c), 4.4 and 14 of this Plan. Notwithstanding any other provision of this Plan to the contrary, the Committee may amend this Plan, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming this Plan to any present or future law relating to plans of this or similar nature, and to the administration regulations and rulings promulgated thereunder. By accepting an Incentive Award under this Plan, a Participant agrees to any amendment made pursuant to the preceding sentence to any Incentive Award granted under this Plan without further consideration or action.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">19.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Substituted Awards</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Committee may grant Incentive Awards under this Plan in substitution for stock and stock-based awards held by employees of another entity who become Employees of the Company or a Subsidiary as a result of a merger or consolidation of the former employing entity with the Company or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the former employing corporation. The Committee may direct that the substitute Incentive Awards be granted on such terms and conditions as the Committee considers appropriate in the circumstances.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">20.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Effective Date and Duration of this Plan</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Plan is effective as of the Effective Date. This Plan will terminate at 11:59 p.m., Eastern Time, on the day before the tenth (10<sup style="vertical-align:top;line-height:120%;">th</sup>) anniversary of the Effective Date, and may be terminated prior to such time by Board action. No Incentive Award will be granted after termination of this Plan. Incentive Awards outstanding upon termination of this Plan will remain outstanding in accordance with their applicable terms and conditions and the terms and conditions of this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">21.<u> </u></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;"><u>Miscellaneous</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.1.&nbsp; &nbsp;<u>Usage</u>. In this Plan, except where otherwise indicated by clear contrary intention, (a) any masculine term used herein also will include the feminine, (b) the plural will include the singular, and the singular will include the plural, (c) &#8220;including&#8221; (and with correlative meaning &#8220;include&#8221;) means including without limiting the generality of any description preceding such term, and (d) &#8220;or&#8221; is used in the inclusive sense of &#8220;and/or&#8221;.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.2.&nbsp; &nbsp;<u>Unfunded Plan</u>. Participants will have no right, title or interest whatsoever in or to any investments that the Company or its Subsidiaries may make to aid it in meeting its obligations under this Plan. Nothing contained in this Plan, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other individual. To the extent that any individual acquires a right to receive payments from the Company or any Subsidiary under this Plan, such right will be no greater than the right of an unsecured general creditor of the Company or the Subsidiary, as the case may be. All payments to be made hereunder will be paid from the general funds of the Company or the Subsidiary, as the case may be, and no special or separate fund will be established and no segregation of assets will be made to assure payment of such amounts except as expressly set forth in this Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.3.&nbsp; &nbsp;<u>Relationship to Other Benefits</u>. Neither Incentive Awards made under this Plan nor shares of Common Stock paid pursuant to such Incentive Awards under this Plan will be included as &#8220;compensation&#8221; for purposes of computing the benefits payable to any Participant under any pension, retirement (qualified or non-qualified), savings, profit sharing, group insurance, welfare, or benefit plan of the Company or any Subsidiary unless provided otherwise in such plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.4.&nbsp; &nbsp;<u>Fractional Shares</u>. No fractional shares of Common Stock will be issued or delivered under this Plan or any Incentive Award. The Committee will determine whether cash, other Incentive Awards or other property will be issued or paid in lieu of fractional shares of Common Stock or whether such fractional shares of Common Stock or any rights thereto will be forfeited or otherwise eliminated by rounding up or down.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.5.&nbsp; &nbsp;<u>Governing Law; Venue</u>. The validity, construction, interpretation, administration and effect of this Plan and any rules, regulations and actions relating to this Plan will be governed by and construed exclusively in accordance with the laws of the State of Delaware, notwithstanding the conflicts of laws principles of any jurisdictions. Unless otherwise expressly provided in an Incentive Award Agreement, the Company and recipients of an Incentive Award under this Plan hereby irrevocably submit to the exclusive jurisdiction and venue of the federal or state courts of the State of Delaware to resolve any and all issues that may arise out of or relate to this Plan or any Incentive Award Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.6.&nbsp; &nbsp;<u>Successors and Assigns</u>. This Plan will be binding upon and inure to the benefit of the successors and permitted assigns of the Company and the Participants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.7.&nbsp; &nbsp;<u>Construction</u>. Wherever possible, each provision of this Plan and any Incentive Award Agreement granted under this Plan will be interpreted so that it is valid under the Applicable Law. If any provision of this Plan or any Incentive Award Agreement granted under this Plan is to any extent invalid under the Applicable Law, that provision will still be effective to the extent it remains valid. The remainder of this Plan and the Incentive Award Agreement also will continue to be valid, and the entire Plan and Incentive Award Agreement will continue to be valid in other jurisdictions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.8.&nbsp; &nbsp;<u>Delivery and Execution of Electronic Documents</u>. To the extent permitted by Applicable Law, the Company may: (a) deliver by email or other electronic means (including posting on a Web site maintained by the Company or by a third party under contract with the Company) all documents relating to this Plan or any Incentive Award hereunder (including prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements), and (b) permit Participants to use electronic, internet or other non-paper means to execute applicable Plan documents (including Incentive Award Agreements) and take other actions under this Plan in a manner prescribed by the Committee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: Times New Roman; text-align: center;">23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.9.&nbsp; &nbsp;<u>Corporate Action Constituting Grant of Awards</u>. Corporate action constituting a grant by the Company of an Incentive Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Committee, regardless of when the instrument, certificate or letter evidencing the Incentive Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (<i>e.g.</i>, Board or Committee consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (<i>e.g.</i>, exercise price, vesting schedule or number of shares) that are inconsistent with those in the Incentive Award Agreement or related grant documents as a result of a clerical error in the papering of the Incentive Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Incentive Award Agreement or related grant documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.10.&nbsp;<u>No Representations or Warranties Regarding Tax Effect; No Obligation to Minimize or Notify Regarding Taxes</u>. Notwithstanding any provision of this Plan to the contrary, the Company and its Subsidiaries, the Board, and the Committee neither represent nor warrant the tax treatment under any federal, state, local, or foreign laws and regulations thereunder (individually and collectively referred to as the &#8220;Tax Laws&#8221;) of any Incentive Award granted or any amounts paid to any Participant under this Plan including, but not limited to, when and to what extent such Incentive Awards or amounts may be subject to tax, penalties, and interest under the Tax Laws and have no duty or obligation to minimize the tax consequences of an Incentive Award to the holder of such Incentive Award. The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising an Incentive Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Incentive Award or a possible period in which the Incentive Award may not be exercised.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.11.&nbsp;<u>Indemnification</u>. Subject to any limitations and requirements of Delaware law, each individual who is or will have been a member of the Board, or a Committee appointed by the Board, or an officer or Employee of the Company to whom authority was delegated in accordance with Section 3.1 of this Plan, will be indemnified and held harmless by the Company against and from any loss, cost, liability or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under this Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company&#8217;s approval, or paid by him or her in satisfaction of any judgment in any such action, suit or proceeding against him or her, provided he or she will give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his/her own behalf. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which such individuals may be entitled under the Company&#8217;s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or pursuant to any agreement with the Company, or any power that the Company may have to indemnify them or hold them harmless.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">24</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex_608212.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_608212.htm</title>

	<!-- Generated by ThunderDome Portal - 12/19/2023 12:13:58 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<div>
<div><img alt="biokeylogo.jpg" src="biokeylogo.jpg"></div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>to Regain Compliance with Nasdaq Minimum Bid Price Requirement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Wall, NJ </b>&#8211;<b> December 19, 2023 </b>&#8211; <u><b>BIO-key International, Inc.</b></u> (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring <u>Identity-Bound Biometrics (IBB)</u>, today announced that it has approved a 1-for-18 reverse stock split that will become effective with the commencement of trading on December 21, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">BIO-key had approximately 16.9 million shares of common stock issued and outstanding as of December 19, 2023. After giving effect to the 1-for-18 reverse stock split, BIO-key will have approximately 941,000 shares of common stock issued and outstanding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">BIO-key CEO Michael DePasquale commented, &#8220;We view our Nasdaq listing as an important stockholder and corporate asset. In order to regain compliance with Nasdaq&#8217;s $1 minimum closing bid price requirement, a reverse stock split was required. The Board&#8217;s decision to set the ratio at 1-for-18 was intended to position our common stock for ongoing minimum bid price compliance as we execute on our growth and profitability goals in 2024 and beyond.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About BIO-key International, Inc. (</b><u><b>www.BIO-key.com</b></u><b>)</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BIO-key Safe Harbor Statement</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All statements contained in this press release other than statements of historical facts are &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;). The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management&#8217;s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy debt repayment obligations and working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Engage with BIO-key:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Facebook &#8211; Corporate:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<u>https://www.facebook.com/BIOkeyInternational/</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">LinkedIn &#8211; Corporate:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>https://www.linkedin.com/company/bio-key-international</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Twitter &#8211; Corporate:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>@BIOkeyIntl</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Twitter &#8211; Investors:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>@BIO_keyIR</u><u> </u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">StockTwits:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>BIO_keyIR</u><b><u> </u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Investor Contacts:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">William Jones, David Collins</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Catalyst IR</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u><b>BKYI@catalyst-ir.com</b></u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">212-924-9800</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bkyi-20231214.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/19/2023 12:14:21 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:bkyi="http://www.bkyi.com/20231214" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bkyi.com/20231214">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20231214_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20231214_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20231214_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.bkyi.com/20231214/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="bkyi_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>bkyi-20231214_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/19/2023 12:14:21 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.bkyi.com/20231214/role/statement-document-and-entity-information" xlink:href="bkyi-20231214.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.bkyi.com/20231214/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>bkyi-20231214_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/19/2023 12:14:21 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_CurrentFiscalYearEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line Two</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>bkyi-20231214_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/19/2023 12:14:21 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.bkyi.com/20231214/role/statement-document-and-entity-information" xlink:href="bkyi-20231214.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.bkyi.com/20231214/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>biokeylogo.jpg
<TEXT>
begin 644 biokeylogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M+]MM/^"=;?%YC^U]) ER/A4G@GQY)BW?P&?B6LK^+D\--X+1/^$,']K,7\0
MJ2+)@+[_ $>OO>OX3OA7IL7BK_@];^+U\"\R^#/AUK.I,3&1Y,MO^QQX.\/;
M>"1L277E42-C+2*H&2IKUCX,_NQHKYA_:]_;(_9S_81^"6O_ +0O[47Q'T[X
M:?"_P_>Z9I4NJW-IJ&K:IJ^MZS<"VTO0/#/AS1K:^UWQ)KEXPFN$TS1K"[N8
MM/M+_4[A(=.T^]NH)_V2OVL_A)^VQ\%M _:#^!0\<W?PI\6W%W'X/\1>.OAY
MXO\ AK-XML+/RD;Q#X=T7QMI6BZUJ7ABYG>2VTWQ#'8#2]5EM;LZ=<W44#2D
M ^EZ*_,?]N[_ (+"_P#!/S_@G'?:=X:_:=^.EAH_Q)UJSM]1T7X/>"-&U?XA
M?%;4;"\<QV5])X0\+VM[/H5C?L'&FW_BBXT*QU,QRKIUQ=-#*$^'_!O_  <[
M_P#!+C6?%/A[PQ\2M6_:*_9LB\67*6OAWQ9^T7^SSXV\ >"M3>5E6*8>([#_
M (2.ULK%]RL^I:DEEIUI$?.OKJUA5Y% /Z&**^5/VC_VT_V>/V5_V9]7_; ^
M*7C.>Z_9YT33O"NMWOQ$^'>AZO\ %#36\.^--4TO2/#OB:QB\!VFNW.I^&[Z
M\UK2R=<TZ*YTZ&UO(KZ6=;3=,N_^R?\ M7? W]MOX#>"/VE?V<?%[^./A%\0
MEUK_ (1K7YM(U;0+R6;P[KVI^&=9M+_0]=M+#5]+O+'6-(OK:6VO[."4K&DZ
M*T$T4C@'T916+XD\1:)X0\.Z]XM\3:G::)X;\+Z+JGB+Q#K-_*L%AI&AZ)8S
MZEJVIWL[?+#:6%A;7%U<RM\L<,3N>!7PW^P7_P %-?V1O^"EGA_XA^+?V0_&
M7BKQ_P"%?A?KFD^&O%GB/6OAOXY\":1%K^LV5QJ5KI.EW?C/1-%&M7T&G01W
MVHPZ8MPVF6U_I<E_Y']I68E /OZBOB:S_;?\$ZA\5+3X>6?@WQ7<:/?>)K'P
MK:>-(38RVTUUJ?C"R^'VGZ[_ &)%(]_#X/N_&NI:?H4&NW4UO-)]MM]1CTM]
M-D^U#[9H&TUNCX$_X*7?L1>&_P!OO]DOXA? W4$L;+QO';-XO^#WBB[C3/A;
MXI:!:W4GARZDG(WPZ3K0FN?#'B0(<OX?UK4&13<16[)_FN>#H_$G@/Q7XI^$
M'CW2;[PWXL\)Z[K>BW^@:M&T.H:%XCT&^GL/$GAN[0DA+FSOK:Y*H"4:2*Y,
M;,CQ$_ZSU?AW_P %8O@9_P $W_@;\'_B%^VA^T%^Q)8_&7Q<WB/P_%JNM?#>
MQO/"GC'5O%FM/#I&@ZUXU\:>']7T.31]$>ZM=/TO5?%6HQZM+%)/IUH+#4;N
M[MK:3\ZX\X2I9W068T\1A\%7PE&H\36KJI[.>'IQ=2$Y.C2JU.>B^9*T)<U.
M<H_9BC^FOH[^,V,\/\TCP]7RW,L\P.;YA066X'+9X7ZW3QV+G3P^(P]*.-Q.
M$P[HXZ"HSM/$TXT<5AZ=5+]]6D?R&?LZ_LG_ !P_:@UJ_P!/^%?A7S/#_A^,
MW?C;XC^);VW\+_##X?:7'&9[G5O&WCG5FAT31;:VM5>Z-J)[C5KF"-VT_3;Q
ME*U[?XF_:/\ V+_V%)O^$>_9NT3P_P#MU_M8VCF!_CKXUT6YG_9D^%VOH "W
MPA^',YCO_B]K>E7(;['XR\4O;^&5N+>UU;1X+J)IK%?E']H7]N3]HK]M+1[7
MX<V)\,_L^?LK^%[K[-X7_9T^#MNWAWX<:6D!$L,FO6EJUOJOQ'\4E6AN+WQ!
MXQF>VDORU_8:;ILDKPGPOP_X5T7PO#Y>EVH$[*%GU"<B:_N?7S+@@>7'Z6]N
ML4*XQM8C)_$'B<MR?W<!#Z]CXVOF&*I1]G1EI=X+"SYX46MXXC$JMBM(U*=/
M SNC_0&.6<8^(2]IG]=\,<+U?AX=RO%5'BL?2OMGF<4'0KXZ,XZ5<LRR6"RA
M7J8?%8KB"BDS4^)/C'XZ_M+^.+_XI?M/?%3QE\1_%>J7'VEK76]=N+B&Q3.Z
M*PL+*V:'1?#.D6P^2UT#PQ8V%C:H-L?DL6!]D^&_QT^-/P>ELIOA5\6?B1\/
M#ITD<MK%X1\:^)-$MD>,J4\VTLM2CM+E?E&Y+N&=) -LBN"0?*O;_/UR/_U=
MZ.WY?UKQJF/QM6L\3/$U_;2ESNHJM13YNLG/FYW)O5R<G)O>3/T3 \*\.Y?E
M\,KH9/E\L%"DJ/U>M@\-5I.E%**I^RE2]C&E965&G3A1BOAIH_N!_P"",7_!
M2+QA^V3X-\7_  F^-MW::C\;/A18:;JL/BNVM[;3W^(G@6^E_LY-8U+3[1(;
M2'Q-H.J+%8Z]-86]M9:A!J6D7\=K!=27ZU^XU?R,?\&X_P "/%]W\4OC-^T=
M=V5[8^ ]$\&#X4Z/J$L3Q6?B'Q7K>KZ1X@UFTL9& 6['AK2]'T]M2:/<EO<:
MY81,QE,BQ_USU_3G >.S#,.&,!B<RE4J5VZU.%>K=U<1AZ=64*-6<GK.5DZ?
MM'>554U4E*4IN3_R1^D=D'#/#7BYQ)E?"E+#X7+HQR_$XC+\&HQPF6YEB\#1
MQ&.P6&A#W*-)5)JO]6IVIX2=>6%IPI4Z,:4/X>/VKO%'[2&G?\'&WC+Q!^R5
M\-O"?Q<^._A#2- _X1'P-XUU2'0?#6HP0_LR:9#X@GU+49_$OA..-]-T#4]0
MO[4'7+0W5W#;1(ESN^S2?J)XJ_:4_P"#D&?0=1CT7]A#]F31-0-O-Y&IZ?XT
M\.:W?VQV$B2RTV__ &@6L[FZ7&88[F&>%GPLD,@^4_(/[/TB^)/^#H_X]ZAQ
M(- TKQZB,H0A&TOX#>$/"S_>VX9)+B2)C&#+OSU0RL/[ :PR7+ZF,_MJM',L
MQP:GGN91]GA*M"%-VE37M'[3#U9J;^&\9I<L8VL[M_1^(G%6&X>7ASE]?@_A
M/B"IA_"_@RK]:S_"9IB,53Y\/B)?5HK"9O@L-]6BU[10J8:<W.M4YYR@XPC_
M !J_\$GKWX)^(_\ @HUXF\9?\%'/%?QEC_X*HW6K:C;>$_!/QX\':-X/^'.C
M:N^E/::=%\-;C3M1OK?4_$T7@PK;>!;&^L/">@6NCW$I\ Z3KE^;'6$_53_@
MXUU 6?\ P2\^)%L6"_VM\3/@]IXSC+&/QG::H%7)!S_Q+=QP&PBL6 0.R_CA
M_P %Y?&?AKQ]_P %7?V+?!?P"N[#5_V@_ S?"_P[XFO/#)6ZU'3/&VJ?%VVU
MGX:>'-6GL TB:[H,<\^M7-I*QN=/TKQ#8-<^1$ZJOZD_\'-.M+IO_!.32=-+
MXD\1?M$_#/3@HR!(EGH'CO6GXS@A7TR)L$G!"D E<CEI5%A\FXKRY<E58#VT
M7C8WY\9/%49<\L3*4Y^TQ5.2]G6FFE)\J4(I:^YBL)/-?$/P(XNG]9P;XHEE
M=>/#E9T_JO#^'R/,:,:%#)J-.CAUA<CQ=&2Q.78>5.=2$?:U)XBO*HY+ZQ_X
M)'W5UX1_X)#?LT:Q9P/+>:3\$?&7B.T@15+SW \1^-M;MD15'S/.[1[0P+DN
M ^6R*_%#_@U<TJU\2^-/VY/BOK;KJ'CB\C^%.ESZI/M>\:U\5:O\1O$NOOO)
M\S;JFKZ7IUQ=<%7ELX,D-'BOWY_X)(:; O\ P3'_ &-;"XBBEM[WX$^'Y)X<
M9CFAU9KZ[E249Y:9+MOM X_>-(,#H/YFOV+/B)%_P1#_ ."LGQU_9Y_:$:X\
M)_LZ_'9VTOPU\0+VWDCT&R\,7/B._P!=^"?Q(GN4+1-X>L+74M<\!^-KB 2+
MX=UBYU&YOFBL_#]TS].(:PD^"\=7?+@\/0^K5JDM*=&KBL!1IX><WM%.<6N=
MV45%MM'DY3"IGN%^D;PUEB=7B+-LTCG& PE/7$YA@,CXJQ^,S7#X:"3G6JQH
MU:;CAZ2E4KRJ1A&,K']PU%4-*U72]=TVPUG1-2L-8T?5;2WU#2]6TJ\M]0TW
M4K"[B6>UO;"^M))K6\M+F%TFM[FWEDAFB=9(W9&!*:MJVE:#IFH:WKFIZ?HV
MC:39W.HZKJ^K7EOIVF:9I]G$\]W?ZA?WDD-I96=K CS7-U<RQP01(\DKJBDC
M[BZM>ZM:]^EM[WVM;J?S-R3Y_9\LN?FY.3E?/SWY>7EM?FOIRVO?2US^2S_@
MZ\T_0_\ A77[&VL2B)/$L'C/XPZ?92  7+:'-H/@BZU(!L[C%!J%KI# $;5D
MF)W(3\W]#/@G]JK]G[X8_"[X,>'_ (Z?M$?!#X9?$:]^#/PQU_6/#7Q(^+?@
M/P7XF8ZKX3TYI-3DT;Q-K^F:H;2\OX+](;QK;R+B6WN%CD9HI O\K'[8'C@_
M\%S_ /@JU\%?V>_@#]K\3?LN?L[%X/&/Q(M()G\/7GAG^WM-U?XQ?$"VN24B
MCTSQ$FDZ#\.?A\TVU]>U.UMM6M=VEZJSVO[P_MJ?\$&/^";/_!0'XRQ?'K]I
MGX4>,?%'Q%M_!7AGX?6]]X?^*WCWP;I=OX6\(B^&AV$.B^'-9L=.1K9=1N5>
MX$/G3 IYC'8*^6R22Q><\09E0][!U:F#PE&JM85ZF$H<E>I!K2<(R:49IN,E
M+1Z'[?XD4IY%X>^%'!V9)T\_P&$XAS[,<%4TQ&5X3B#,88G+,-B(.\Z%>K0A
M.K6PU2,:M&<+5(1;5_T/\$_M:?LK?$OQ-IW@KX<?M,?L_?$#QEK'VHZ1X2\$
M_&7X<^*_$VJ?8;2:_O?[.T'0O$E_JM]]CL;:XO;K[-:R_9[2":XEV0Q.Z_PZ
M>!OVD_@Y^S!_P=6_\%0OVIOC[XOA\'?"3X#_ +/_ (ZU[Q-KL[B_N<V?P[_9
MR\%:;H&B6*-'/JWB+Q!K>J1:'X=\/V2O>WFK7MM9 +&MQ<Q?TO?L?_\ !OI_
MP3#_ &%OC]X._:9_9S^$7C3PQ\7/ =MXCM/#6M:W\6_B!XMT^SB\5>'M2\+Z
MR9-$\0:U>Z9<23:-JU];PRRP&2W>7SH65U!K^;W]@[X/?#']K_\ X.9_^"UG
MPL^-'A33_'WPL\:?";]HKX9^-/#6KVZ7-EJ>BQ_$KX)^#2L=RQ>XTW4+"71H
M+_0M4T^2&_TK5+"SU+3I[.[L;9XOJC\./=_V7OV;/V@/^#EO]J+P]_P4*_;J
M\-ZS\,O^"6GP7\2:M!^Q[^RA=WLB#XU2Z9JLMEJ'B/Q@MM.@O=*OKS3(8OB-
MXNC15\375F?AQX*DA\-Z3K.IQ_UE?M>?';PO^Q#^QC\>OC]:^']*MO#?[.'P
M+\7>+O#?A#3K6#2M$9_!?A>=/!OA"PLK$6MMINEW>I6^C^'[2ULD@BL[6:.*
MUC18XT'\B'[)OQN^+O\ P;,_MU#_ ()\?M=^*]=\9?\ !++]ISQ3JGB']DW]
MH77%GNK;X.ZSJNI1)<6VOW$$ MM,M;.]O]/TCXR>'[6*&RTJ\NM(^+NA6UEH
MVM:]9ZC_ $Z?\%=_A!XC_:8_X):_MM_"WX9Q?\)%XF\=?LX>-=0\%6FD2QW9
M\3:CH6FQ>,]&TW2I89&AO'\0MHD-AI[0R/'=/?0^47$BY /XD_\ @@I^W=_P
M2J^%_C/]H#_@H5_P5._:*T+Q1_P4)^,_Q=UZ\\.W/Q!^&7Q)^(EY\-O!XL]/
MNYO%'AB[T;P3XD\/:+KWBK5+^]T6QETZY2^\*^#/"^C^'M%_LG3;V_M;K^@G
M]L[_ (+=?\&]W[;?[-?Q9_9Q^-'[4'A+QAX6^(?@WQ!I%A_:_P $OC7=7GAC
MQ/<:7=1^&_&/AF]F^&#SZ)XH\-:PUIJNBZO9/#/;7=LBN[6TD\4GS;_P:->/
M_P!E7X\_\$[M5_9^\1^"OA'XC^/G[._Q2\=S>+M \5>#_!VK>-+OP#\0-9'B
MCPEXQ3^U-.N-6O\ 0?[1U'6?"<EX3)'IM_H4=C<FW6ZTU)_ZN/\ AG#]GG_H
M@WP8_P##7>!__E'0!_';_P &N=YJ'[>G_!'[]N#]@'XV:K=>*OACX8\3>+O@
M_P""M1U(WEY_PCO@7XW> ;G48=.T=KIQ+#!X2\:6^K^,=!MXQ ^F7FK0^7'"
M(X57O_\ @T2^,OBOX:>'?VZ_^"7?Q=>6P^*'[(WQWUSQ5I>B76_?#H^L:M<?
M#[XBV5@)=LHT[1?'W@^SU4;8DA=_'27*@/<NTG]AOA+P!X$\ 6]Y9^!/!/A+
MP5::C<)=:A:^$O#>C>&[>^NHXA#'<WD&C65E%=7$<($233J\B1 1JP08K^+#
M]L72IO\ @EE_P=(?LJ_M6:4G]B_ O_@I?HUM\+?B2\?FVVDCQSXH;1?A9XJC
MNF0K$#9^,X/@S\4+Z242++=ZIJ,I 8.\8'ZGZ)_\'4?[<FH?LP_\$[+C]GKX
M=7EV_P <_P!NCQ(/@1X0TK1V=]>'P]?['<_%?4+"W@<74IU73+W1OARD<4;/
M--\0%,/[R#C](O\ @C5^P1IW_!.#_@GI\!?V<IK"UMOB*- 7XA_'"^@6,R:G
M\9/'D-MK'C&.:XC %W#X9)L?!&E7'\>B>%]-;[Q8G^=KP'H\G_!:G_@Y;\;?
M$W4$_P"$B_8V_P""0]M9^%_#22JMYX;\2_&GPMKFH0Z7LS$]E<W.J?&2V\2^
M+5N%WI?>%OA)H%M,6BND+?VV4 ?+-C^R'\+M.\<P^,K>Y\2):VOBL^-;7PBE
MWI<.@0Z^/$6G>,;9'O;;2(?%5WX=TWQEH^D^+=)\(WOB.Y\,Z9K^F6%S9Z9%
M:VEM91?4U%% VV[>05YW\7/A5X'^.7PP\>_![XEZ)!XB\!?$GPMK'@_Q7H]P
M%VWFCZW9R6=SY,C*QMKVW\Q;O3[V,>?8W\%M>6[)/!&Z^B45,HQG&4)Q4H3B
MXRC)7C*,E:46GHTTVFGNBZ-:KAZU+$4*DZ->A4A6HUJ4I0J4JM*2G3J4YQ:E
M"<)Q4H2BTXR2:::/\K_]I;]G7QM^P%^UQ\3OV:OB#)-<V6@:W''H/B*>,Q6_
MBSP/J^Z]^'WCVVPB0G^U-*ECMM:2 -'I^LQ:WICL9=*<+"05R#P0<$>I&?Y<
M=?K[5_:__P %Q_\ @E1XC_X*#_#OX>>.O@5IOAI/VDOA9J;Z-:2>(-6B\.V/
MC/X7:U]IGU?PM?ZO+#-;I>Z%KAM=?\,R7OEV]N;KQ'9^=%_;+.OX3?LS?\$'
MOV^O'WC"W\$?'3POHWP+\-^'OL\6O?$C5O$?AGQO;ZII89E@_P"$0TOPEKM_
M-KVN&"/RY8M2N-#T^!D2>\OU,T=O+_-_$W N;X?.)TLKR_%8S"UZJ^JU*5-R
MIQIU/>A"M7=J=%T;.E.5:<(N,(5&TI,_U*\'_I$<%XS@JEB.,>)LIR/,LOPD
MIYCAL;B84\3+$89QABJF!P,%+%8NECVX8W"X? T*\XU:V(PT8SJ4TG^2_A;P
MIXF\<>(=(\)>#?#VM>*O%&O7D>GZ+X>\/:9=ZSK.JWLQQ';:?IMA#/=W4QY;
M9#$Y5%9V(168?TO_ +"O_!O]J^N)H_Q'_;:U&Y\/:9)Y%_9? OPIJ<:Z]=QE
M1)%'X_\ %FGR2PZ/$^[%SX?\,3S:EM^2XU_3)UFLA^]_['O_  3[_9J_8F\.
MQ6'PC\&QW7C*ZL8K3Q)\5?%2VVK_ !#\2L$7SUGUG[-#'H^ES2AI4T#P];:7
MHT3$,UI-<;[B3[:K[?AGPOPF#]GB^()0QV)5IQP--OZE2EH[5I>[+%R76-H8
M?>,H5HVD?@_BS]+W.\]^LY)X:TL1PYE+YZ57B+$Q@N(,=!^ZW@::=2EDM&2O
MRU8RKYDUR5:=? 5.>D<9\/?AUX%^$_@[0_A]\-?">A>"/!7AJS6PT/PUX<T^
M#3=*T^V4EF$5O JAYIY&>>[NIC+=7ES)+=7<TUQ+)*W9T45^LPA"G"-.G"-.
MG"*A"$(J,(0BK1C&,4HQC%))12225DK'\75Z]?$UJN)Q-:KB,17J3K5Z]>I.
MK6K5JLG.I5JU:CE.I4J3;G.<Y.4Y-RDVVV?S@_%'_@A+\8?$O[8?QG_;&^$7
M_!0'Q?\  ;Q[\6O%_BO7H9/!'PSO8=;\.:%XHDB$OAA?$UE\3]*N;^UBM+:U
MM9I19V*72P(3:Q!0M;-__P $=?V_=>LKC1]?_P""U7[3EQH]^GD:A;V>A^++
M2XFMV.)(TN8OC5%+'O0LIVR*&!VON3*G^B6BO%_U=RKFJ2C2Q$/:U)U:BIX_
M'TX3J5'S3FX4\3&%Y/?W;6TM;0_1EXN<=^RPE*>89576 PF%P.#J8KA;A7%X
MBAA,%3C2PM&&)Q.2U:_+0A!*'-4;3O*[DVS\;?V$/^"(_P"RG^Q!X]C^-0U/
MQE\>/CW!)J%QIWQ/^*<]C,?#5]JT5Q!JVJ>%/#FGP+9Z?K6IPW=U%<Z_K%[X
MAU^..ZNH[+5+-+N[6?U__@J3_P $[Y?^"DWP3\$?!L?%H_"&W\(_$RR^(L^M
M#P<?&9U1K'PUXC\/0Z7]@_X27PR+49\0O=F[-U<'-N(A /,,B_IG177'*,NA
M@:F6PPL*>#JW]K1IN</:7<6Y3J1DJLIOEBG-S<VDE>R2/#J<>\75^),'Q=B<
M[Q6*XAR^4)8+'XN-#$_553C4C3IX?"UJ4\%2H0]K4E##T\/&A&<YU(TU.3D_
MG[]E/X%K^S)^S=\%/V?4\0CQ:OP?^'?ASP%_PDZZ7_8G]OG0+%+-M6.D_;]3
M_L][UD,[VO\ :%V(W=@)W%><?MF_L%_LS_MY^ ;;P'^T-X%76WT9KJ?P?XVT
M2Y&B?$#P+>WBQK<W7A;Q+%#-+;PW?DP'4-'U&WU+P_JIM[9M4TF\:UMFA^R*
M*Z983#3PRP<Z,*F&5*-'V-2/M(.G!*,8M3O?E459N\KI2O?4\:CGN;X?.'Q!
MA<PQ6$SEXRMF']HX.H\)B88O$5)U*U6G/#^S5/VDJE3FA!1IN$Y4^7V;<3^8
MS0?^"&7[:?[.)ET;]BC_ (*H?%7X;?#XRRO9> O&&DZXVF:<DDC2'$.A>)[C
MPK/<L3F:[LO!.C/,[-(8U/!MZQ_P0S_;&_:,:WTG]N'_ (*F_%[XH_#U)X9;
M[X>>"M,U>STO4TBD$F&_M[Q$?"T%P& \JZN_ >KO"5#*F[&W^FBBO)_U:RFW
M)[+$^P6V&^OX[ZM;33V'UCDY=/A:Y>EK:'WK\9>/7/ZQ]=R99EO_ &RN%>&%
MG/-_S\_M/^R/K7M=/XRFJU_>]IS:GR?^R%^Q+^SC^PU\.&^&G[.W@&V\*Z;?
MS6]]XH\1WT[:OXU\<:M;Q-#%JWB_Q-<J+S5+B%'E6RLHQ::-I*3SPZ-I>G03
M21-]8445[5&C2P]*%&A3A1I4URPITXJ$(1[1C%)+771:MMO5GYQC\PQV:XS$
M9CF>,Q./Q^+J.KB<9C*U3$8FO4=ESU:U64IS=DHJ[?+%**M%)(K\&OV#O^"*
M,_[%W_!2_P#;%_X*)WG[1K?$N[_:R_X6GYGPP7X:GPK%X*'Q(^*FB_$B-?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140070748568960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">BIO-key International, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Dec. 14,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">1-13463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">41-1741861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">101 Crawfords Corner Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity, Address, Address Line Two</a></td>
<td class="text">Suite 4116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Holmdel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">07733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">359-1100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BKYI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001019034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>bkyi20231218_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bkyi-20231214.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001019034</identifier>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0001019034</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-12-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">BIO-key International, Inc.</dei:EntityRegistrantName>
    <dei:CurrentFiscalYearEndDate contextRef="d20238K">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">1-13463</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">41-1741861</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">101 Crawfords Corner Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="d20238K">Suite 4116</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="d20238K">Holmdel</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">07733</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">359-1100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20238K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K">BKYI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #&0Y-7!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M ,9#DU= BS0([0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( ,9#DU>97)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ QD.35](/
MQB]X!   WQ$  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( ,9#DU>?H!OPL0(  .(,   -
M  "  ;H,  !X;"]S='EL97,N>&UL4$L! A0#%     @ QD.35Y>*NQS
M$P(   L              ( !E@\  %]R96QS+RYR96QS4$L! A0#%     @
MQD.35SJJHN=  0  / (   \              ( !?Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( ,9#DU<D'INBK0   /@!   :              "
M >P1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,9#
MDU=ED'F2&0$  ,\#   3              "  =$2  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  !L4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bkyi20231218_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bkyi.com/20231214/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bkyi-20231214.xsd</File>
    <File>bkyi-20231214_def.xml</File>
    <File>bkyi-20231214_lab.xml</File>
    <File>bkyi-20231214_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="bkyi20231218_8k.htm">bkyi20231218_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bkyi20231218_8k.htm": {
   "nsprefix": "bkyi",
   "nsuri": "http://www.bkyi.com/20231214",
   "dts": {
    "schema": {
     "local": [
      "bkyi-20231214.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bkyi-20231214_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bkyi-20231214_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bkyi-20231214_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "bkyi20231218_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 28,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.bkyi.com/20231214/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20238K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bkyi20231218_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20238K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bkyi20231218_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.bkyi.com/20231214/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-23-034827-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-034827-xbrl.zip
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ME$EO RXM;>5&M$%6_1<__P!02P,$%     @ QD.35VB?X=<#!0  YB\  !4
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M_PI\!9.&M^%F\@4;VD]N(L9K\K)7S^&F$)'.,-.L54S/-^3,0LY)(I!OL%*
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M[,!+C'Z#A%QKDI6C_5 *NU_ P0KWL5?O$I."UPDZ%V!_IF/_8DZTX4Y,:V"
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M/ $JC7_W.(^NEP)R\F[=O.D6>7F-;^CDO3;\X]U<P/C(6" 'CV( ^ZGH@^&
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MDY6Q*'24G*T/4N<#QT>CCQ^^:<,9]#OT)0]$T:3?I3'?[0_L?P)02P,$%
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M3<&]M_&G\!]S;:^Q*[.R9Y_623:AWI1UBSL*1C0O< KQ)47%3C<:[99&21.
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MJ2=C>^JGK&B2O[#F_'<,3>\0_=+^5.N!RTQN(3J#^.K4\0/O@FL41J%@0:_
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M=95D4%UZ)1/LN@'"-]OQ85R7GJ:VLCDB&<);>I<E&-ELS'T7.9 >!L:@SBD
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M$?7AW38R&/@UU9T(@^Z9A[<C@TPL.MW1D6/!];GPUO;WL=MZ2/^Q-<=Y%XB
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MZ5OR,Y*IRU'XU+O_>&,X"#(^Z#;TX6\L RKE&BX#UR\.@"0CL<#PL$F(\+[
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M X1/8 S7TG=A (F"!7"#- S8=, 3AH,2\ 54(PL 9#P5IGL*A2:V @L!"SK
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M7_C__J#Q\!^,_P502P$"% ,4    " #&0Y-7J;X0GV8#  !P#0  $0
M        @ $     8FMY:2TR,#(S,3(Q-"YX<V102P$"% ,4    " #&0Y-7
M:)_AUP,%  #F+P  %0              @ &5 P  8FMY:2TR,#(S,3(Q-%]D
M968N>&UL4$L! A0#%     @ QD.35\;JMTLZ!@  BT   !4
M ( !RP@  &)K>6DM,C R,S$R,31?;&%B+GAM;%!+ 0(4 Q0    ( ,9#DU?8
MD=PQG00  .PP   5              "  3@/  !B:WEI+3(P,C,Q,C$T7W!R
M92YX;6Q02P$"% ,4    " #&0Y-7.)X^,"<9   (H   $P
M@ $(%   8FMY:3(P,C,Q,C$X7SAK+FAT;5!+ 0(4 Q0    ( ,9#DU>2>I&_
MT 8  &<?   -              "  6 M  !E>%\V,#<X-#<N:'1M4$L! A0#
M%     @ QD.35[HI;US?:   X:$"  T              ( !6S0  &5X7S8P
M-S@T."YH=&U02P$"% ,4    " #&0Y-7:>'>(Y4+  #(*   #0
L    @ %EG0  97A?-C X,C$R+FAT;5!+!08     "  ( /H!   EJ0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
